Robert Gallo | Academic Influence

Robert Gallo's AcademicInfluence.com Rankings

Robert Gallo

Biology

#45

World Rank

#87

Historical Rank

#28

USA Rank

Virology

#2

World Rank

#2

Historical Rank

#2

USA Rank

biology Degrees

Download Badge

Biology

Robert Gallo's Degrees

Bachelors Biology Providence College

Similar Degrees You Can Earn

Best Online Bachelor's in Biology

Why Is Robert Gallo Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert Charles Gallo is an American biomedical researcher. He is best known for his role in establishing the human immunodeficiency virus as the infectious agent responsible for acquired immune deficiency syndrome and in the development of the HIV blood test, and he has been a major contributor to subsequent HIV research.

(See a Problem?)

Robert Gallo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma (1980) (4663)
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. (1984) (3532)
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells (1995) (2825)
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. (1984) (2653)
Selective in vitro growth of T lymphocytes from normal human bone marrows. (1976) (2325)
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture (1977) (2099)
Complete nucleotide sequence of the AIDS virus, HTLV-III (1985) (2071)
The role of mononuclear phagocytes in HTLV-III/LAV infection. (1986) (1769)
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. (1985) (1657)
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. (1982) (1608)
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. (1978) (1570)
Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). (1983) (1223)
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. (1984) (1109)
A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. (1982) (1094)
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. (1995) (911)
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients (1990) (895)
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation (1993) (855)
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant (2020) (807)
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS (1986) (784)
ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX (1986) (733)
Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia (1981) (733)
Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. (1986) (712)
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA (1986) (600)
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide (1979) (599)
Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. (1984) (598)
The trans-activator gene of HTLV-III is essential for virus replication (1986) (594)
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. (1998) (592)
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. (1988) (587)
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma (1994) (582)
onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient (1982) (570)
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. (1986) (559)
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. (1984) (556)
Human T-lymphotropic retroviruses (1985) (555)
The human type‐C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T‐cell leukemia/lymphoma (1982) (546)
Isolation and transmission of human retrovirus (human t-cell leukemia virus). (1983) (544)
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. (1984) (543)
The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection (1996) (533)
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia (1979) (529)
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. (1986) (508)
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. (1979) (497)
Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. (1983) (496)
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. (1989) (488)
ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIES (1982) (487)
Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. (1982) (486)
Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. (1986) (473)
Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells (1982) (454)
Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. (1985) (443)
Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. (1985) (433)
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions (1987) (430)
Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. (1983) (404)
Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. (1985) (394)
Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. (1984) (389)
Functional and morphologic characterization of human T cells continuously grown in vitro. (1977) (389)
The sor gene of HIV-1 is required for efficient virus transmission in vitro. (1987) (382)
HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex (1985) (378)
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. (1993) (371)
Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL‐60) by compounds which induce differentiation of murine leukemia cells (1980) (369)
Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia. (1982) (361)
Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. (1984) (360)
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. (1985) (355)
HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. (1984) (353)
Differential expression of the amv gene in human hematopoietic cells. (1982) (351)
Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. (1983) (340)
Multiple sclerosis and human T-cell lymphotropic retroviruses (1985) (330)
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction (2001) (330)
Extracellular vesicles and viruses: Are they close relatives? (2016) (329)
A pathogenic retrovirus (HTLV-III) linked to AIDS. (1984) (328)
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. (1988) (328)
Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. (1983) (325)
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6 (1989) (324)
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6) (1988) (322)
Complete nucleotide sequences of functional clones of the AIDS virus. (1987) (321)
Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. (1991) (320)
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. (1984) (319)
Molecular cloning and characterization of the HTLV-III virus associated with AIDS (1984) (318)
HTLV-III in cells cultured from semen of two patients with AIDS. (1984) (314)
Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. (1994) (314)
Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. (1995) (309)
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. (1988) (309)
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. (1986) (306)
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines (1992) (301)
DETERMINANTS OF RETROVIRUS (HTLV-III) ANTIBODY AND IMMUNODEFICIENCY CONDITIONS IN HOMOSEXUAL MEN (1984) (299)
A molecular clone of HTLV-III with biological activity (1985) (299)
Human T lymphotropic virus type III infection of human alveolar macrophages. (1986) (293)
Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). (1982) (292)
Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. (1981) (292)
Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. (1993) (289)
The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group (1982) (287)
Molecular biology of human T-lymphotropic retroviruses. (1985) (286)
Biologically diverse molecular variants within a single HIV-1 isolate (1988) (282)
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 (1995) (281)
Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses (1987) (281)
The discovery of HIV as the cause of AIDS. (2003) (276)
Nucleotide sequence of cloned cDNA of human c-myc oncogene (1983) (272)
Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6 (1991) (271)
Classification of HHV-6A and HHV-6B as distinct viruses (2014) (266)
T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. (1980) (265)
Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. (1982) (260)
Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes. (1981) (257)
Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. (1992) (256)
Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody (1981) (250)
Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations (1992) (249)
Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. (1980) (248)
Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. (1995) (243)
Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS. (1983) (242)
Genomic analysis of the human B-lymphotropic virus (HBLV). (1986) (242)
Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes. (1981) (240)
RNA Dependent DNA Polymerase of Human Acute Leukaemic Cells (1970) (240)
Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone (1995) (234)
SEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROME (1984) (231)
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). (1985) (230)
Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus. (1983) (230)
Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages (1990) (228)
Angiogenic properties of human immunodeficiency virus type 1 Tat protein. (1995) (227)
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. (1992) (227)
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus (1986) (226)
C-C chemokines, pivotal in protection against HIV type 1 infection. (1998) (226)
HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONS (1984) (224)
Chromosomal localization of the human homolog (c-sis) of the simian sarcoma virus onc gene. (1982) (223)
Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. (1971) (223)
Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses (1981) (222)
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. (1985) (222)
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees (1990) (220)
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects. (1986) (213)
Infection of natural killer cells by human herpesvirus 6 (1993) (212)
Human herpes virus‐6 increases HIV‐1 expression in co‐infected T cells via nuclear factors binding to the HIV‐1 enhancer. (1989) (211)
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. (1992) (209)
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. (1998) (208)
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. (1999) (208)
FEMALE PROSTITUTES: A RISK GROUP FOR INFECTION WITH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III (1985) (207)
The Enigmas of Kaposi's Sarcoma (1998) (206)
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). (1986) (206)
Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures (1991) (206)
Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells. (1975) (205)
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. (1998) (205)
T4 POSITIVE HUMAN NEOPLASTIC CELL LINES SUSCEPTIBLE TO AND PERMISSIVE FOR HTLV-III (1984) (200)
RNA of RNA Tumour Viruses contains Poly A (1972) (199)
Viral DNA carried by human immunodeficiency virus type 1 virions (1992) (198)
CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. (1994) (198)
Epidemiology of human T-cell leukemia/lymphoma virus. (1983) (197)
Association of the human type C retrovirus with a subset of adult T-cell cancers. (1983) (197)
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. (1985) (195)
Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. (1982) (192)
The pathologic spectrum of adult T‐cell leukemia/lymphoma in the United States: Human T‐cell leukemia/lymphoma virus‐associated lymphoid malignancies (1984) (191)
EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO (1985) (188)
A survey of human leukaemias for sequences of a human retrovirus (1983) (188)
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. (1986) (186)
Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. (1985) (184)
The discovery of the first human retrovirus: HTLV-1 and HTLV-2 (2005) (184)
Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene (1988) (181)
Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission (1994) (177)
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection (1987) (176)
Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24 (1988) (175)
Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions (1993) (174)
Inhibition of HIV-1 Infection by the β-Chemokine MDC (1997) (173)
Risk of Nosocomial Infection with Human T-Cell Lymphotropic Virus III (HTLV-III) (1985) (172)
Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene. (1984) (172)
Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. (1986) (171)
Alteration of T-cell functions by infection with HTLV-I or HTLV-II. (1984) (169)
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization (1997) (167)
Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus (1981) (167)
Recombinant Vaccine-Induced Protection against the Highly Pathogenic Simian Immunodeficiency Virus SIVmac251: Dependence on Route of Challenge Exposure (1998) (166)
Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. (1984) (164)
HIV/HTLV gene nomenclature (1988) (162)
A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS (1988) (162)
Cytokines and Growth Factors in the Pathogenesis of AIDS‐Associated Kaposi's Sarcoma (1992) (162)
Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma. (1982) (162)
Reverse transcriptase activity of human acute leukaemic cells: purification of the enzyme, response to AMV 70S RNA, and characterization of the DNA product. (1972) (161)
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. (1987) (160)
Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. (2005) (158)
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. (1998) (158)
Origin of the HIV-susceptible human CD4+ cell line H9. (1989) (158)
ISOLATION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE III FROM THE TEARS OF A PATIENT WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME (1985) (156)
Transformation of NIH 3T3 cells by a human c-sis cDNA clone (1984) (155)
The human T-cell leukemia-lymphoma virus in the southeastern United States. (1983) (155)
The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. (1990) (154)
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. (1986) (154)
Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status. (1999) (153)
Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients. (1986) (153)
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. (1986) (153)
Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans (1988) (153)
Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. (1986) (151)
Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. (1998) (151)
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. (1992) (149)
Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. (1991) (149)
HBLV (orHHV-6) in human cell lines (1987) (149)
INFECTION OF CHIMPANZEES BY HUMAN T-LYMPHOTROPIC RETROVIRUSES IN BRAIN AND OTHER TISSUES FROM AIDS PATIENTS (1985) (148)
Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. (1990) (148)
Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. (1984) (147)
NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. (1984) (147)
Multiple isolates and characteristics of human T-cell leukemia virus type II (1992) (147)
A human onc gene homologous to the transforming gene (v-sis) of simian sarcoma virus (1981) (146)
gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? (1998) (146)
Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. (1984) (146)
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. (1994) (145)
Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line (1983) (145)
Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. (1995) (145)
Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS. (1985) (143)
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding (2012) (141)
Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. (1999) (138)
History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2 (2005) (137)
AIDS in 1988. (1988) (137)
Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. (1985) (137)
Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors. (1987) (136)
A reflection on HIV/AIDS research after 25 years (2006) (136)
Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. (1991) (134)
Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas (1981) (133)
Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. (1981) (133)
A Sound Rationale Needed for Phase III HIV-1 Vaccine Trials (2004) (133)
Chromosomal sublocalization of human c-myb and c-fes cellular onc genes (1983) (133)
T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells. (1984) (132)
Hydrocortisone and some other hormones enhance the expression of HTLV‐III (1986) (132)
Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine (1999) (132)
Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. (1994) (132)
Higher macrophage inflammatory protein (MIP)-1α and MIP-1β levels from CD8+ T cells are associated with asymptomatic HIV-1 infection (2000) (131)
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV β-chemokines: An approach to suppress R5 strains of HIV-1 (2003) (131)
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6) (1988) (130)
Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. (1993) (127)
Immunological Relationship of DNA Polymerase from Human Acute Leukaemia Cells and Primate and Mouse Leukaemia Virus Reverse Transcriptase (1973) (127)
The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. (1996) (123)
HUMAN T-CELL LEUKAEMIA/LYMPHOMA VIRUS-ASSOCIATED LYMPHORETICULAR NEOPLASIA IN JAMAICA (1983) (122)
Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses (2006) (121)
Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus. (1982) (121)
Development and early natural history of HTLV-III antibodies in persons with hemophilia. (1985) (120)
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection (2015) (119)
The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemia. (1983) (119)
Transmission of HTLV-I and HIV among homosexual men in Trinidad. (1987) (119)
Envelope sequences of two new United States HIV-1 isolates. (1988) (118)
Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. (1987) (118)
Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. (1997) (118)
Characterization of long terminal repeat sequences of HTLV-III. (1985) (118)
Purification, Characterization, and Comparison of the DNA Polymerases from Two Primate RNA Tumor Viruses (1973) (117)
Heterosexually acquired HTLV-III/LAV disease (AIDS-related complex and AIDS). Epidemiologic evidence for female-to-male transmission. (1985) (116)
Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients (1983) (115)
Evidence for exposure to HTLV-III in Uganda before 1973. (1985) (115)
Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. (1997) (114)
Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex. (1985) (112)
Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. (1994) (112)
Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes. (1986) (111)
Human herpesvirus 6 in AIDS. (1995) (111)
Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia (1984) (111)
HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis. (1987) (109)
HIV causes AIDS. (1988) (109)
Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. (1992) (109)
The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma. (1983) (108)
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly. (1990) (108)
ORIGIN OF HUMAN T-CELL LEUKAEMIA-LYMPHOMA VIRUS (1983) (107)
The family of human T-lymphotropic leukemia viruses: HTLV-I as the cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency syndrome. (1985) (107)
Type-restricted neutralization of molecular clones of human immunodeficiency virus. (1988) (106)
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny (1983) (105)
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment. (1992) (105)
Interleukin-15 as an activator of natural killer cell-mediated antiviral response. (1999) (105)
Infective transmission and characterisation of a C-type virus released by cultured human myeloid leukaemia cells (1975) (105)
DNA polymerases of normal and neoplastic mammalian cells. (1978) (105)
Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease. (1987) (105)
Control of HIV-1 infection by soluble factors of the immune response (2004) (104)
Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein. (1995) (104)
Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. (1995) (103)
Reducing the global burden of HTLV‐1 infection: An agenda for research and action (2017) (102)
Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. (1986) (101)
Cell lines producing human T-cell lymphoma virus show altered HLA expression (1983) (100)
Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T‐cell leukemia‐lymphoma virus (HTLV) (1983) (100)
Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages (1993) (99)
Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. (1989) (99)
Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. (1987) (99)
HBLV (or HHV-6) in human cell lines. (1987) (97)
Transfer RNA species in normal and leukemic human lymphoblasts. (1970) (97)
Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy (1991) (96)
HTLV-III, LAV, ARV are variants of same AIDS virus (1985) (95)
Human herpesvirus-6 strain groups: a nomenclature (1993) (95)
Natural antibodies to human T‐cell leukemia/lymphoma virus in healthy venezuelan populations (1984) (94)
Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. (1985) (94)
Inhibition of HTLV-III/LAV replication by foscarnet. (1985) (94)
Human T-cell leukemia-lymphoma virus (HTLV). (1983) (94)
Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance. (1997) (94)
Role of β-Chemokines in Suppressing HIV Replication (1996) (93)
HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells. (1999) (93)
Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120 (1989) (93)
Novel viral sequences related to human T-cell leukemia virus in T cells of a seropositive baboon. (1984) (93)
Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates. (1993) (92)
Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. (1984) (92)
Isolation and characterization of a T lymphocyte-derived differentiation inducing factor for the myeloid leukemic cell line HL-60. (1984) (92)
Viral and Cellular DNA Polymerase: Comparison of Activities with Synthetic and Natural RNA Templates (1972) (91)
Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses. (1986) (91)
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. (2000) (90)
Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease. (1986) (90)
Prospects for the Future (2002) (90)
Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans (1997) (89)
HTLV-III SEROPOSITIVITY IN EUROPEAN HAEMOPHILIACS EXPOSED TO FACTOR VIII CONCENTRATE IMPORTED FROM THE USA (1984) (89)
Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro (1995) (89)
Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor (1983) (89)
Disseminated human herpesvirus 6 infection In AIDS (1993) (88)
IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model (2009) (88)
TNFα kinoid vaccination-induced neutralizing antibodies to TNFα protect mice from autologous TNFα-driven chronic and acute inflammation (2006) (87)
AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin. (1991) (86)
Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection. (1988) (85)
Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. (1986) (85)
Increased Interferon Alpha Expression in Circulating Plasmacytoid Dendritic Cells of HIV-1-Infected Patients (2008) (84)
Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX. (1984) (84)
Detection of human anti‐HTLV‐III antibodies by indirect immunofluorescence using fixed cells (1985) (84)
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro. (1985) (84)
Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development (2014) (84)
Pathogenesis of AIDS-associated Kaposi's sarcoma. (1991) (83)
Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia. (1978) (83)
Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex. (1992) (83)
Geographic distribution of HTLV‐I and identification of a new high‐risk population (1988) (83)
Oncogene expression in human leukemia. (1984) (83)
Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens (2007) (83)
Can existing live vaccines prevent COVID-19? (2020) (82)
Quantitative PCR for human herpesviruses 6 and 7 (1995) (82)
A human T-lymphotropic retrovirus (HTLV-III) as the cause of the acquired immunodeficiency syndrome. (1985) (81)
Transformation of different phenotypic types of human bone marrow T‐lymphocytes by htlv‐1 (1984) (81)
Terminal deoxynucleotidyltransferase in chronic myelogenous leukemia. (1974) (80)
DNA-dependent DNA polymerases I and II from normal human-blood lymphocytes. (1972) (80)
The chronology of AIDS research (1987) (80)
A papular eruption associated with human T cell lymphotropic virus type III disease. (1985) (79)
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. (1998) (79)
Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis virus onc genes. (1982) (79)
Human T-cell leukemia-lymphoma virus and adult T-cell leukemia. (1983) (79)
Antibodies against three purified proteins of the human type C retrovirus, human T-cell leukemia-lymphoma virus, in adult T-cell leukemia-lymphoma patients and healthy Blacks from the Caribbean. (1983) (78)
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice (2015) (78)
Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. (1998) (77)
Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus (1983) (77)
Human herpesvirus 6A accelerates AIDS progression in macaques (2007) (77)
Time to eradicate HTLV-1: an open letter to WHO (2018) (77)
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection (2009) (76)
Molecular Biology: Reverse Transcriptase, the DNA Polymerase of Oncogenic RNA Viruses (1971) (76)
Polymerase chain reaction amplification and in situ hybridization for the detection of human B-lymphotropic virus. (1988) (76)
VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases (2007) (75)
Primate RNA tumor virus-like DNA synthesized endogenously by RNA-dependent DNA polymerase in virus-like particles from fresh human acute leukemic blood cells. (1973) (75)
In vitro generation of an HTLV-III variant by neutralizing antibody. (1986) (75)
Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. (1986) (75)
HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques (1995) (74)
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene (1987) (74)
Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. (1990) (74)
The Early Years of HIV/AIDS (2002) (74)
In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). (1992) (74)
Molecular cloning and analysis of a new variant of human T‐cell leukemia virus (HTLV‐Ib) from an African patient with adult T‐cell leukemia‐lymphoma (1984) (74)
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope (1990) (74)
Molecular studies of HHV-6. (1988) (73)
Human retroviruses after 20 years: a perspective from the past and prospects for their future control (2002) (73)
Human herpesvirus 6 in AIDS (1994) (73)
Induction of Neutralizing Antibodies to T-Cell Line-Adapted and Primary Human Immunodeficiency Virus Type 1 Isolates with a Prime-Boost Vaccine Regimen in Chimpanzees (1998) (73)
Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. (1990) (72)
Adrenal corticosteroids enhance production of type-C virus induced by 5-iodo-2'-deoxyuridine from cultured mouse fibroblasts. (1973) (72)
Human T-cell leukemia/lymphotropic virus type III in the conjunctival epithelium of a patient with AIDS. (1985) (72)
Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses. (1984) (72)
Isopentenyladenosine Stimulates and Inhibits Mitosis of Human Lymphocytes Treated with Phytohemagglutinin (1969) (72)
Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphoma virus type I: parameters of virus integration and expression. (1985) (72)
Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans. (1985) (71)
Human herpesvirus 7 (HHV-7) strain JI: independent confirmation of HHV-7. (1992) (70)
HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor (2002) (70)
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. (2002) (70)
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1 (2008) (70)
Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques (2000) (69)
Relationships between components in primate RNA tumor viruses and in the cytoplasm of human leukemic cells: implications to leukemogenesis. (1975) (69)
Human T-cell leukemia-lymphoma virus (HTLV): cloning of an integrated defective provirus and flanking cellular sequences. (1983) (69)
Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III. (1985) (69)
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. (1989) (68)
Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I (1985) (68)
Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein. (1984) (68)
Complete amino acid sequence of human T‐cell leukemia virus structural protein p15 (1983) (68)
Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II (1994) (68)
HTLV-III in the tears of AIDS patients. (1986) (68)
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates (1992) (67)
Human DNA Polymerase III (R-DNA Polymerase): Distinction from DNA Polymerase I and Reverse Transcriptase (1974) (67)
Molecular cloning of a unique human T-cell leukemia virus (HTLV-IIMo). (1984) (67)
Reverse transcriptase, RNA tumour virus transformation and derivatives of rifamycin SV. (1972) (66)
Rifamycin antibiotics: inhibitors of Rauscher murine leukemia virus reverse transcriptase and of purified DNA polymerases from human normal and leukemic lymphoblasts. (1972) (66)
High incidence of human type-C retrovirus (HTLV) in family members of a HTLV-positive Japanese T-cell leukemia patient. (1983) (66)
Relationship between RNA-directed DNA polymerase (reverse transcriptase) from human acute leukemic blood cells and primate type-C viruses. (1974) (66)
Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine. (1999) (65)
Inhibition of HIV-1 infection by the beta-chemokine MDC. (1997) (65)
Seroepidemiologic Studies Of Human T‐cell leukemia/lymphoma virus type I in Jamaica (1985) (65)
Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1. (1988) (65)
The purification and properties of human T cell growth factor. (1982) (65)
DNA polymerases in human lymphoblastoid cells infected with simian sarcoma virus. (1974) (65)
Occurrence of human T cell lymphotropic virus (type I) antibodies in cutaneous T cell lymphoma. (1986) (64)
Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus. (1984) (64)
Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity. (1989) (64)
Regional variation in prevalence of antibody against human T‐lymphotropic virus types I and III in Kenya, East Africa (1985) (63)
Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1 (2020) (63)
DIVERSE TROPISM OF HUMAN B-LYMPHOTROPIC VIRUS (HUMAN HERPESVIRUS 6) (1987) (63)
The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. (1998) (63)
Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes (1991) (63)
Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease (1998) (63)
Human T cell leukaemia virus associated lymphoproliferative disease: report of two cases in Nigeria. (1984) (63)
Growth and differentiation in culture of leukemic leukocytes from a patient with acute myelogenous leukemia and re-identification of type-C virus. (1975) (63)
Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. (2000) (63)
Long terminal repeat structure of an American isolate of type I human T-cell leukemia virus. (1984) (62)
Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. (1987) (62)
The Exceptional Oncogenicity of HTLV-1 (2017) (62)
Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma. (1989) (61)
Virus Hunting: Aids, Cancer, And The Human Retrovirus: A Story Of Scientific Discovery (1991) (61)
HTLV‐III infection of EBV‐genome‐positive B‐lymphoid cells with or without detectable T4 antigens (1987) (61)
Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. (1986) (61)
CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses (1990) (60)
Severe molluscum contagiosum infection in a patient with human T cell lymphotrophic (HTLV-III) disease. (1985) (60)
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. (1985) (60)
Molecular cloning and comparative analyses of the genomes of simian sarcoma virus and its associated helper virus. (1981) (60)
Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. (1991) (60)
RNA processing and RNA tumor virus origin and evolution. (1975) (60)
Stimulated normal human lymphocytes contain a ribonuclease-sensitive DNA polymerase distinct from viral RNA-directed DNA polymerase. (1972) (59)
Detection of Antibodies to Human T-Cell Lymphotropic Virus-III (HTLV-III) with an Immunoassay Employing a Recombinant Escherichia coli-Derived Viral Antigenic Peptide (1985) (59)
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line. (1984) (59)
Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope (1990) (58)
A New Monoclonal Antibody, mAb 4A12, Identifies a Role for the Glycosaminoglycan (GAG) Binding Domain of RANTES in the Antiviral Effect against HIV-1 and Intracellular Ca2+ Signaling (1998) (58)
The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. I. Substrate inhibition by thymine and activation by phosphate or arsenate. (1967) (58)
Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes. (1988) (57)
Indirubin-3′-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication (2005) (57)
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. (1985) (57)
Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin. (1988) (57)
Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes. (1995) (56)
Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. (1993) (56)
Subgroup G HIV type 1 isolates from Nigeria. (1994) (56)
Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques. (1996) (56)
Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals wi (1985) (55)
Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. (1996) (55)
Reverse Transcriptase in Normal Rhesus Monkey Placenta (1974) (55)
AIDS-associated Kaposi's sarcoma: a molecular model for its pathogenesis. (1989) (55)
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis (2015) (55)
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses (2003) (55)
40 years of the human T-cell leukemia virus: past, present, and future (2019) (55)
Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. (2004) (54)
Proviral sequences of baboon endogenous type C RNA virus in DNA of human leukaemic tissues (1976) (54)
Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. (1985) (54)
The case for a family of reverse transcriptase viruses: Retraviridae. (1974) (54)
Genetic origin of RD114 and other RNA tumour viruses assayed by molecular hybridization. (1973) (54)
Anti-inflammatory effects of H2S during acute bacterial infection: a review (2017) (53)
CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1 (2007) (53)
Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics (2021) (53)
Sequence of the envelope glycoprotein gene of type II human T lymphotropic virus. (1984) (51)
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. (1990) (51)
Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements. (1988) (51)
Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. (1987) (50)
Comparative inhibition of purified DNA polymerases from murine leukemia virus and human lymphocytes by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate. (1974) (50)
Anti-cytokine Ab immune therapy: present status and perspectives. (2004) (50)
STLV‐I antibodies in feral populations of East African vervet monkeys (Cercopithecus aethiops) (1986) (50)
Long-term suspension cultures of human cord blood myeloid cells. (1981) (50)
Antitat gene therapy: a candidate for late-stage AIDS patients. (1995) (50)
Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. (2003) (49)
A unique human immunodeficiency virus culture secreting soluble gp160. (1988) (49)
IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells (2011) (49)
In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo (1990) (49)
Mechanism of Stimulation of Murine Type-C RNA Tumor Virus Production by Glucocorticoids: Post-Transcriptional Effects (1974) (49)
Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1. (1994) (49)
Colony-stimulating factors in cultures of human peripheral blood cells. (1974) (49)
Characterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeast (2017) (49)
Evidence against transmission of human T‐lymphotropic virus/lymphadenopathy‐associated virus (HTLV‐III/LAV) in families of children with the acquired immunodeficiency syndrome (1985) (49)
Immunological and biochemical characterisation of type C viruses isolated from cultured human AML cells (1976) (49)
Retrovirus Biology and Human Disease (1989) (49)
The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. (1993) (48)
The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. IV. Comparisons between normal and leukemic leukocytes. (1969) (48)
Identification of HTLV p19 specific natural human antibodies by competition with monoclonal antibody. (1982) (48)
Covid‐19: Time for a paradigm change (2020) (48)
Toward a new generation of vaccines: The anti-cytokine therapeutic vaccines (2001) (47)
Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells. (1999) (47)
Human T‐cell leukaemia virus (HTLV) in the United Kingdom (1984) (47)
HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes. (1999) (46)
Perspective on Kaposi's sarcoma: facts, concepts, and conjectures. (1999) (46)
Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. (1990) (46)
HTLV-I-SPECIFIC ANTIBODY IN AIDS PATIENTS AND OTHERS AT RISK (1984) (46)
Murine intracisternal type A particles: a biochemical characterization (1975) (46)
Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits. (1995) (45)
Primate type-C virus nucleic acid sequences (woolly monkey and baboon types) in tissues from a patient with acute myelogenous leukemia and in viruses isolated from cultured cells of the same patient. (1976) (45)
Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization. (1996) (45)
Kaposi's sarcoma in Zaire is not associated with HTLV-III infection. (1984) (45)
Mycoplasma promotes malignant transformation in vivo, and its DnaK, a bacterial chaperone protein, has broad oncogenic properties (2018) (44)
Human Herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms: necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. (1997) (44)
Cordycepin inhibits induction of murine leukovirus production by 5-iodo-2'-deoxyuridine. (1972) (44)
Surface antibodies of human myelogenous leukaemia leukocytes reactive with specific type-C viral reverse transcriptases (1978) (44)
Current concepts of leukemia and lymphoma: etiology, pathogenesis, and therapy. (1976) (43)
An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS (1985) (43)
RNA-dependent DNA polymerase in viruses and cells: views on the current state. (1972) (43)
Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection. (1996) (43)
HIV-1 transgenic rats develop T cell abnormalities. (2004) (43)
Deletion and translocation involving chromosome 3 (p14) in two tumorigenic Kaposi's sarcoma cell lines. (1996) (43)
Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells. (1984) (42)
Information transfer in cells infected by RNA tumor viruses and extension to human neoplasia. (1975) (42)
Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study. (1988) (42)
The v-sis transforming gene of simian sarcoma virus is a new onc gene of primate origin (1981) (42)
Persistent in vitro infection by human T‐cell leukemia‐lymphoma virus (HTLV) of normal human T‐lymphocytes from blood relatives of patients with HTLV‐associated mature T‐cell neoplasms (1983) (42)
Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV (1984) (42)
CD4 Promoter Transactivation by Human Herpesvirus 6 (1998) (42)
Selective toxicity of rifamycin derivatives for leukaemic human leucocytes. (1972) (41)
Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III). (1985) (41)
Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-κB inhibition (2014) (41)
Three distinct genes in human DNA related to the transforming genes of mammalian sarcoma retroviruses. (1981) (41)
Biological and molecular characteristics of human herpesvirus 7: in vitro growth optimization and development of a syncytia inhibition test. (1994) (41)
Clonal analysis of the response of human myeloid leukemic cell lines to colony-stimulating activity. (1981) (41)
Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model. (2007) (40)
Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element (1993) (40)
In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells. (1996) (40)
Reactivity of HTLV-transformed human T-cell lines to MHC class II antigens (1984) (40)
CD4 IS NOT THE MEMBRANE RECEPTOR FOR HHV-6 (1989) (40)
Relatedness by nucleic acid hybridization of new isolates of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of provirus in uncultured leukemic blood cells. (1983) (40)
Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression. (1984) (40)
The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years (2005) (40)
Research and discovery of the first human cancer virus, HTLV-1. (2011) (40)
Polymorphism of human herpesvirus 6 DNA from five Japanese patients with exanthem subitum. (1989) (39)
Correlation of transfer RNA methylase activity with growth and differentiation in normal and neoplastic tissues. (1970) (39)
Rauscher-leukemia-virus-related sequences in human DNA: presence in some tissues of some patients with hemotopoietic neoplasias and absence in DNA from other tissues. (1977) (39)
Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin. (1999) (39)
Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma. (1998) (39)
Abundant transcription of a cellular gene in T cells infected with human T-cell leukemia-lymphoma virus. (1983) (39)
The role of chemokines in human immunodeficiency virus infection (2000) (39)
Systematics of RNA tumor viruses and virus-like particles of human origin. (1974) (39)
Retrovirus sequences in a leukemic gibbon and its contact: evidence for partial provirus in the nonleukemic gibbon. (1979) (39)
DNA Polymerases from RNA Tumor Viruses and Human Cells: Inhibition by Polyuridylic Acid (1972) (38)
Characterization of the endogenous feline leukemia virus-related DNA sequences in cats and attempts to identify exogenous viral sequences in tissues of virus-negative leukemic animals. (1980) (38)
Human retroviruses (1991) (38)
Genetic relationship of a primate RNA tumour virus genome to genes in normal mice (1975) (38)
RNA-directed DNA polymerase from human leukemic blood cells and from primate type-C virus-producing cells: high- and low-molecular-weight forms with variant biochemical and immunological properties. (1975) (38)
Tat toxoid as a component of a preventive vaccine in seronegative subjects. (1999) (38)
Methylation of human T-cell leukemia virus proviral DNA and viral RNA expression in short- and long-term cultures of infected cells. (1984) (38)
IFN-α2b Reduces IL-2 Production and IL-2 Receptor Function in Primary CD4+ T Cells (2000) (38)
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases (2012) (38)
Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes. (1996) (38)
Beta-chemokines and protection from HIV type 1 disease. (1998) (38)
Human retroviruses and adult T-cell leukemia-lymphoma. (1982) (37)
Th2 Polarization in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus (HIV)-Infected Subjects, as Activated by HIV Virus-Like Particles (2008) (37)
trans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor protein (1985) (37)
Human gene (c-fes) related to the onc sequences of Snyder-Theilen feline sarcoma virus (1982) (37)
Cell surface antigen expression in newborn cord blood lymphocytes infected with HTLV. (1983) (36)
Human retroviruses: a decade of discovery and link with human disease. (1991) (36)
IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. (1985) (36)
Viral genomes in lymphomas of patients with Sjögren's syndrome. (1989) (36)
Characterisation of a virus (HL23V) isolated from cultured acute myelogenous leukaemic cells (1976) (36)
International NeuroAIDS: prospects of HIV-1 associated neurological complications (2005) (36)
Characterization of Rauscher murine leukemia virus envelope glycoprotein receptor in membranes from murine fibroblasts (1978) (36)
RNA-directed DNA polymerase and virus-induced leukemia in mice. (1973) (36)
POSSIBLE RISK TO RECIPIENTS OF BLOOD FROM DONORS CARRYING SERUM MARKERS OF HUMAN T-CELL LEUKAEMIA VIRUS (1982) (36)
Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia. (1984) (35)
A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice (2002) (35)
Establishment of long-term monocyte suspension cultures from normal human peripheral blood (1982) (35)
A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection. (1994) (35)
Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM. (1987) (34)
Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus. (1984) (34)
Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7. (1998) (34)
Unexplained Persistent Lymphadenopathy in Homosexual Men and the Acquired Immune Deficiency Syndrome (1985) (34)
Precipitation of nucleic acids with cetyltrimethylammonium bromide: a method for preparing viral and cellular DNA polymerase products for cesium sulfate density gradient analysis. (1972) (34)
Cytomegalovirus but not human T lymphotropic virus type III/lymphadenopathy associated virus detected by in situ hybridisation in retinal lesions in patients with the acquired immune deficiency syndrome. (1986) (34)
Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element. (1995) (34)
ERYTHROPOIETIC RESPONSE IN CHRONIC PULMONARY DISEASE. (1964) (34)
DNA polymerase gamma of human lymphoblasts. (1977) (34)
Modern Trends in Human Leukemia IV (1981) (34)
Preclinical Evaluation of Synthetic −2 RANTES as a Candidate Vaginal Microbicide To Target CCR5 (2006) (33)
Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications. (1985) (33)
Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1. (1994) (33)
POLYMERASE CHAIN REACTION AND IN-VITRO ANTIBODY PRODUCTION FOR EARLY DIAGNOSIS OF PAEDIATRIC HIV INFECTION (1988) (33)
Enhanced induction of growth of B lymphoblasts from fresh human blood by primate type‐C retroviruses (gibbon ape leukemia virus and simian sarcoma virus) (1979) (33)
Reverse transcriptase in type C virus particles of human origin. (1971) (33)
Safety of the hepatitis B vaccine. (1985) (33)
Engagement of CD28 Modulates CXC Chemokine Receptor 4 Surface Expression in Both Resting and CD3-Stimulated CD4+ T Cells1 (2000) (33)
Expression in Escherichia coli of open reading frame gene segments of HTLV-III. (1985) (33)
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB). (1994) (32)
Factors that affect human hemopoiesis are produced by T-cell growth factor dependent and independent cultured T-cell leukemia-lymphoma cells. (1982) (32)
Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus. (1978) (31)
Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection (1989) (31)
5' viral and human cellular sequences corresponding to the transforming gene of simian sarcoma virus. (1983) (31)
Polyadenylic Acid in Visna Virus RNA (1973) (31)
Screening transplant donors for HTLV-1 and -2. (2016) (31)
TRANSMISSION EXPERIMENTS WITH HUMAN T-LYMPHOTROPIC RETROVIRUSES AND HUMAN AIDS TISSUE (1984) (31)
Gibbon ape leukemia virus-Hall's Island: new strain of gibbon ape leukemia virus (1979) (31)
IN-VITRO INHIBITION OF LAV/HTLV-III INFECTED LYMPHOCYTES BY DITHIOCARB AND INOSINE PRANOBEX (1985) (31)
Kyoto Workshop on some specific recent advances in human tumor virology. (1981) (31)
Serological analysis of human deoxyribonucleic acid polymerases. Preparation and properties of antiserum to deoxyribonucleic acid polymerase I from human lymphoid cells. (1975) (31)
Inverse correlation between average monthly high temperatures and COVID-19-related death rates in different geographical areas (2020) (31)
The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. II. Comparison of deoxyribosyl donors. (1968) (31)
Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6. (1994) (30)
Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication (1991) (30)
Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association. (1985) (30)
B cell lymphoma in hiv transgenic mice (2013) (30)
Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro (2007) (30)
Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production. (1985) (30)
Prevalence of HTLV‐I in arctic regions (1985) (30)
Historical essay. The early years of HIV/AIDS. (2002) (30)
HIV Infection and Pathogenesis: What About Chemokines? (1999) (30)
Modern Trends in Human Leukemia III (1979) (30)
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the β-chemokine macrophage inflammatory protein-1β (2001) (30)
Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus. (1988) (30)
AIDS vaccine therapy: phase I trial (1990) (30)
DNA-metabolizing enzymes in normal human lymphoid cells. VI. Induction of DNA polymerases alpha, beta, and gamma following stimulation with phytohemagglutinin. (1975) (29)
Terminal Transferase and Leukemia (1975) (29)
Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. (1997) (29)
Human T-cell leukemia viruses (HTLV): a unique family of pathogenic retroviruses. (1985) (29)
Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice (1994) (29)
Immunological characterization of the low molecular weight gag gene proteins p19 and p15 of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of human natural antibodies to them. (1984) (29)
Relationship between HTLV-III Neutralizing Antibody and Clinical Status of Pediatric Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex Cases (1987) (29)
Human retroviruses in the second decade: A personal perspective (1995) (29)
Utilization of mammalian 70S RNA by a purified reverse transcriptase from human myelocytic leukemic cells. (1973) (28)
Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gag. (1994) (28)
The human T-cell leukemia/lymphotropic retroviruses (HTLV) family: past, present, and future. (1985) (28)
HIV--the cause of AIDS: an overview on its biology, mechanisms of disease induction, and our attempts to control it. (1988) (28)
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication. (2000) (27)
Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma. (1991) (27)
Common site of integration of HTLV in cells of three patients with mature T-cell leukaemia-lymphoma (1983) (26)
Serological analysis of cellular and viral DNA polymerases by an antiserum to DNA polymerase gamma of human lymphoblasts. (1977) (26)
Oncornavirus lytic activity in the serum of gibbon apes. (1978) (26)
Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice (2016) (26)
Antibodies against human T‐cell leukemia/lymphoma virus (HTLV) and expression of HTLV p19 antigen in relatives of a T‐cell leukemia patient originating from Surinam (1983) (26)
Immune functions in homosexual men with antibodies to HTLV-III in Finland. (1985) (26)
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response (2019) (26)
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A (2009) (26)
Identification of simian immunodeficiency virus SIVMAC env gene products (1989) (25)
Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome. (1985) (25)
Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase. (1989) (25)
The Inoue-Melnick virus, human herpesvirus type 6, and the chronic fatigue syndrome. (1989) (25)
Control of allergic reactions in mice by an active anti-murine IL-4 immunization. (2007) (25)
Human herpesvirus 7 induces the down-regulation of CD4 antigen in lymphoid T cells without affecting p56lck levels. (1997) (25)
Modern Trends in Human Leukemia V (1983) (25)
Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands. (1994) (25)
Clonal selection of human T-cell leukemia virus-infected cells in vivo and in vitro. (1984) (25)
AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations. (1998) (25)
Human T-cell growth factor: parameters for production. (1980) (25)
Regulation of human T-cell proliferation: T-cell growth factor and isolation of a new class of type-C retroviruses from human T-cells. (1981) (25)
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant (2020) (24)
The etiology of AIDS. (1985) (24)
HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T cells. (1985) (24)
Hydroxyurea and AIDS: an old drug finds a new application? (1995) (24)
In vitro susceptibility of different human T‐cell subpopulations and resistance of large granular lymphocytes to HTLV‐I infection (1987) (24)
DNA-directed and RNA-primed DNA synthesis in microsomal and mitochondrial fractions of normal human lymphocytes (1974) (24)
HTLV-III and the etiology of AIDS. (1986) (24)
Current thoughts on the viral etiology of certain human cancers: The Richard and Hinda Rosenthal Foundation Award lecture. (1984) (24)
Terminal transferase levels in chronic myelogenous leukemia in blast crisis and in remission (1978) (24)
Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value. (1993) (23)
Agents which inhibit reverse transcriptases. (1974) (23)
Interaction between murine type-C virus RNA-directed DNA polymerases and rifamycin derivatives. (1974) (23)
Shock and kill with caution (2016) (23)
Modern Trends in Human Leukemia II (1976) (23)
Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk. (1985) (23)
Karyotypic differences between primary cultures and cell lines from tumors with the human T-cell leukemia virus. (1984) (23)
Human Herpesvirus 7 Infection Induces Profound Cell Cycle Perturbations Coupled to Disregulation of cdc2 and Cyclin B and Polyploidization of CD4+ T Cells (1998) (23)
A common change of aspartyl-tRNA in polyoma- and SV40 -transformed cells. (1972) (23)
DETECTION OF INFECTIOUS HTLV-III/LAV VIRUS IN CELL-FREE PLASMA FROM AIDS PATIENTS (1985) (22)
Abnormal in vitro proliferation and differentiation of T cell colony- forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers (1993) (22)
Occurrence of HTLV-I antibodies in Danish patients with cutaneous T-cell lymphoma. (2009) (22)
Synthesis of type C virus particles from murine-cultured cells induced by iododeoxyuridine. V. Effect of interferon and its interaction with dexamethasone (1976) (22)
HTLV-III: the etiologic agent of AIDS. (1984) (22)
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques. (2014) (22)
Serologic specificities of methylated base immune systems. (1971) (22)
Human T-cell leukemia/lymphoma virus: the retrovirus of adult T-cell leukemia/lymphoma. (1983) (21)
Functional modifications of alloreactive T cell clones infected with HTLV-I. (1986) (21)
Chemokine Receptors and Chemokines in HIV Infection (1998) (21)
Differential polarization of immune responses by co-administration of antigens with chemokines. (2004) (21)
Antibodies to a DNA:RNA hybrid in systemic lupus erythematosus measured by a cellulose ester filter radioimmunoassay. (1972) (21)
Human Retroviruses: Their Role in Neoplasia and Immunodeficiency (1989) (21)
Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells. (1985) (21)
Antigenic characterization of a new gibbon ape leukemia virus isolate: Seroepidemiologic assessment of an outbreak of gibbon leukemia (1978) (21)
HHV-6 and CMV pneumonitis in immunocompromised patients (1994) (21)
Biological characterization of noninfectious HIV-1 particles lacking the envelope protein. (1992) (21)
Human herpesvirus-6 (HHV-6) (short review). (1991) (21)
Synthesis and metabolism of DNA and DNA precursors by human normal and leukemic leukocytes. A summary of recent information. (1971) (21)
Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. (1985) (21)
Purification and partial characterization of equine infectious anemia virus reverse transcriptase. (1991) (21)
Mechanism of disease induction by HIV. (1990) (20)
Inhibitors of DNA and RNA polymerases (1980) (20)
DEMONSTRATION OF VIRAL ANTIGEN p24 IN CIRCULATING IMMUNE COMPLEXES OF TWO PATIENTS WITH HUMAN T-CELL LEUKAEMIA/LYMPHOMA VIRUS (HTLV) POSITIVE LYMPHOMA (1984) (20)
Nucleotide sequence analysis of the env gene of a new Zairian isolate of HIV-1. (1988) (20)
Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria. (1993) (20)
Human herpesvirus 6. (1995) (20)
Quantitative assays for evaluation of HTLV-III inactivation procedures: tri(N-butyl)phosphate:sodium cholate and beta-propiolactone. (1985) (20)
The human onc gene c-myc: structure, expression, and amplification in the human promyelocytic leukemia cell line HL-60. (1983) (20)
AIDS-associated Kaposi's sarcoma: a new perspective of its pathogenesis and treatment. (1995) (20)
Targeting Tat and IFNα as a Therapeutic AIDS Vaccine (2002) (20)
Common site of integration of HTLV in cells of three patients with mature T-cell leukaemia–lymphoma: a retraction (1983) (20)
Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells. (1995) (19)
Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cells. (1998) (19)
HIV-1, HHV-8, and Kaposi's sarcoma. (1998) (19)
Pathogenesis of AIDS. (1992) (19)
N 6 -( 2 -Isopentenyl)adenosine: the regulatory effects of a cytokinin and modified nucleoside from tRNA on human lymphocytes. (1972) (19)
Uptake of transfer ribonucleic acid by normal and leukemic cells. (1970) (19)
Microenvironment tailors nTreg structure and function (2019) (19)
The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. 3. Inhibition of deoxythymidine phosphorylase by purines. (1968) (19)
Lymphadenopathy in HIV (HTLV-III/LAV) infected subjects: the role of virus and follicular dendritic cells. (1988) (19)
The evidence for involvement of type C RNA tumor viruses in human acute leukemia (1974) (19)
High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals. (1988) (19)
Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV). (1985) (19)
Molecular and immunologic analysis of a chronic lymphocytic leukemia case with antibodies against human T‐cell leukemia virus (1985) (19)
The transfer RNA methylases of human lymphocytes. I. Induction by PHA in normal lymphocytes. (1971) (18)
Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2. (1995) (18)
Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1. (1992) (18)
Effect of cordycepin on the replication of type‐c rna tumor viruses (1975) (18)
Transfer RNA and transfer RNA methylation in growing and "resting" adult and embryonic tissues and in various oncogenic systems. (1971) (18)
HUMAN HERPESVIRUS-6 AND CROSS-REACTIVITY WITH OTHER HERPESVIRUSES (1989) (18)
Characterization of terminal deoxynucleotidyltransferase in a cell line (8402) derived from a patient with acute lymphoblastic leukemia. (1975) (18)
Human Immunodeficiency Viruses (2010) (18)
Transcriptional regulation of a tumor promoter and mitogen-inducible gene in human lymphocytes (1984) (18)
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). (1985) (18)
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists. (2009) (18)
Separation of ribonuclease H and RNA directed DNA polymerase (reverse transcriptase) of murine type-C RNA tumor viruses. (1974) (18)
Selective activation of cervical microvascular endothelial cells by human papillomavirus 16-e7 oncoprotein. (2001) (18)
WHO Working Group on Characterization of HIV-Related Retroviruses: criteria for characterization and proposal for a nomenclature system. (1987) (18)
Location of human T‐cell leukemia virus (HTLV) p19 antigen on virus‐producing cells (1984) (18)
Human trophoblasts: cellular source of colony-stimulating activity in placental tissue (1982) (18)
Transfer RNA methylases of normal cells, virus-transformed cells, and tumors derived from transformed cells. (1971) (18)
Rapid Purification of 70S RNA from Media of Cells Producing RNA Tumor Viruses (1976) (17)
Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments. (2002) (17)
IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells. (2000) (17)
Sequence Variation within the Dominant Amino Terminus Epitope Affects Antibody Binding and Neutralization of Human Immunodeficiency Virus Type 1 Tat Protein (2004) (17)
AIDS Vaccine Research (2002) (17)
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. (2015) (17)
Transcriptional modulation of human T-cell growth factor gene by phorbol ester and interleukin 1. (1984) (17)
Isolation and characterization of a ribonuclease from human leukemic blood cells specific for ribonucleic acid of ribonucleic acid-deoxyribonucleic acid hybrid molecules. (1975) (16)
Reverse transciptase from Mason-Pfizer monkey tumor virus, avian myeloblastosis virus, and Rauscher leukemia virus and its response to rifamycin derivatives. (1972) (16)
Role of Mycoplasma Chaperone DnaK in Cellular Transformation (2020) (16)
Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells (2018) (16)
Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus (1993) (16)
In search of Hodgkin's disease virus. (1981) (16)
Enhanced transformation of human immunocompetent cells by dibutyryl adenosine cyclic 3',5'-monophosphate. (1971) (16)
Charles S. Mott Prize. Human T‐cell leukemia (lymphotropic) retroviruses and their causative role in T‐cell malignancies and acquired immune deficiency syndrome (1985) (15)
Origins of human T-lymphotropic viruses (1986) (15)
Poly (rA) tracts of tumor virus 70S RNA are not transcribed in endogenous or reconstituted reactions of viral reverse transcriptase. (1972) (15)
Schnitzler's syndrome: no evidence for autoimmune basis in two patients (2000) (15)
Antibodies against three purified structural proteins of the human type‐C retrovirus, HTLV, in Japanese adult T‐cell leukemia patients, healthy family members, and unrelated normals (1983) (15)
A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line. (1982) (15)
MONOCLONAL ANTIBODIES TO HIV IN A NON-INFECTED, IMMUNISED VOLUNTEER (1988) (15)
Detection of a histone‐2a related polypeptide in differentiated human myeloid cells (hl‐60) and its distribution in human acute leukemia (1981) (15)
Inhibition of RNA-dependent DNA polymerase by thymidylate derivatives. (1972) (15)
REPAIRING THE T-CELL DEFECT IN AIDS (1985) (15)
A new subtype of HIV-1 gag sequence detected in Taiwan. (1993) (15)
Purification and characterization of gibbon ape leukemia virus DNA polymerase. (1976) (15)
Oncogenic RNA viruses. (1976) (15)
On the historical origins of HIV-1 (MN) and (RF). (1992) (15)
Time to Go Back to the Original Name (2017) (15)
Screening tests for blood donors presumed to have transmitted the acquired immunodeficiency syndrome. (1985) (14)
Use of Old World Monkeys for Acquired Immunodeficiency Syndrome Research (1989) (14)
HTLV-III infection in homosexuals and hemophiliacs in Sweden. (1985) (14)
Molecular epidemiology of HTLV‐I‐Associated non‐Hodgkin's lymphomas in Jamaica (1988) (14)
Chromatographic Analyses of Isoaccepting tRNAs from Avian Myeloblastosis Virus (1973) (14)
Immunopathogenesis of Kaposi’s Sarcoma (1996) (14)
Isolation and characterization of thioguanine resistant human promyelocytic leukemia cells. (1980) (14)
Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III). (1985) (14)
Asparaginyl-tRNA and Resistance of Murine Leukaemias to L-Asparaginase (1970) (14)
A survey on the effect of steroid hormone on type C virus production from cultured murine cells. (1976) (14)
HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation. (2006) (14)
T cell malignancies and human T cell leukemia virus. (1984) (14)
First isolation of HTLV-III (1986) (14)
Modern Trends in Human Leukemia VII (1987) (14)
On the etiology of human acute leukemia. (1973) (13)
Mapping of related and nonrelated sequences of RNA from wooly monkey virus and gibbon ape leukemia virus. (1979) (13)
Transfer RNA Methylase Alterations in Polyoma Transformed Rat Embryo Culture Cells 1 (1971) (13)
Inhibition of human leukocyte pyrimidine deoxynucleoside synthesis by allopurinol and 6-mercaptopurine. (1968) (13)
Terminal deoxynucleotidyl transferase activities in human blood leukocytes and lymphoblast cell lines: high levels in lymphoblast cell lines and in blast cells of some patients with chronic myelogenous leukemia in acute phase. (1976) (13)
In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin. (1986) (13)
Transfer RNA methylase activity in normal monkey liver and in carcinogen-induced hepatoma. (1971) (13)
Modern Trends in Human Leukemia VIII (1989) (13)
Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV. (1987) (13)
Transcription of 70S RNA by DNA polymerases from mammalian RNA viruses (1975) (13)
Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine. (1998) (12)
Human T-cell leukemia/lymphoma viruses: clinical and epidemiologic features. (1985) (12)
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta. (2001) (12)
CHEMOKINES AND HIV INFECTION (1997) (12)
AIDS as a clinically curable disease: the growing optimism. (1996) (12)
Diverse tropism of HBLV (human herpesvirus 6) (1987) (12)
T-CELL LEUKAEMIA-LYMPHOMA VIRUS AND HETEROGENEITY OF CHRONIC T-CELL MALIGNANCIES (1982) (12)
Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome. (1986) (12)
Characterization of a type‐C virus produced by co‐cultures of human leukemic bone‐marrow and fetal canine thymus cells (1979) (12)
Female-to-Male Transmission of HTLV-III-Reply (1986) (12)
Epidemiological evidence that HTLV-III is the aids agent (1985) (12)
Establishment, characterization and differentiation induction of a new human diploid myelomonocytic cell line (HL-92) derived from a patient with acute myelomonocytic leukemia. (1982) (12)
HTLV: The family of human T-lymphotropic retroviruses and their role in leukemia and AIDS (1986) (12)
Seroprevalence of HTLV‐I in portugal and evidence of double retrovirus infection of a healthy donor (1989) (12)
Active and passive anticytokine immune therapies: current status and development. (2012) (12)
Molecular probes for tumor viruses in human cancer. (1976) (11)
Didanosine but not high doses of hydroxyurea rescue pigtail macaque from a lethal dose of SIV(smmpbj14). (1997) (11)
Interaction of C-terminal sequences of human immunodeficiency virus reverse transcriptase with template primer. (1991) (11)
B and T cell reactivities after immunization of macaques with HIV subcomponents. (1988) (11)
COVID-19 Infection Among Women in Iran Exposed vs Unexposed to Children Who Received Attenuated Poliovirus Used in Oral Polio Vaccine (2021) (11)
cDNA sequencing confirms HTLV-I expression in adult T-cell leukemia/lymphoma and different sequence variations in vivo and in vitro. (1992) (11)
Detection of virus-specific RNA in simian sarcoma-leukemia virus-infected cells in in situ hybridization to viral complementary DNA (1979) (11)
Purification and characterization of baboon endogenous virus DNA polymerase. (1977) (11)
Growth of human normal and leukemic T cells: T-cell growth factor (TCGF) and the isolation of a new class of RNA tumor viruses (HTLV). (1981) (11)
Chromatin conformation during cell differentiation of human myeloid leukemia cells. (1979) (11)
Prospects for development of a vaccine against HTLV-III-related disorders. (1987) (11)
Stages in the progression of HIV infection in chimpanzees. (1987) (11)
Interferon-γ Increases Expression of Chemokine Receptors CCR1, CCR3, and CCR5, But Not CXCR4 in Monocytoid U937 Cells (1998) (11)
A surprising advance in the treatment of viral leukemia. (1995) (11)
In vitro cultivation of normal and neoplastic human T lymphocytes. (1984) (11)
Distribution of feline leukemia virus DNA sequences in tissues of normal and leukemic domestic cats. (1979) (11)
Sequence analysis of original HIV-1 (1991) (11)
Epidemiology of human retroviruses. (1985) (11)
RNA-directed and -primed DNA Polymerase Activities in Tumor Viruses and Human Lymphocytes (1973) (11)
Human T-cell leukemia/lymphoma virus : the family of human T-lymphotropic retroviruses, their role in malignancies and association with AIDS (1984) (11)
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). (1989) (11)
Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy (1984) (11)
Antitumor effects of hCG in KS (1998) (10)
Lack of expression of type C hamster virus after neoplastic transformation of hamster embryo fibroblasts by benzo(a)pyrene. (1977) (10)
SOME EVIDENCE FOR INFECTIOUS TYPE-C VIRUS IN HUMANS (1976) (10)
Patterns of conserved gp120 epitope presentation on attached HIV-1 virions (2017) (10)
Terminal deoxynucleotidyl transferase as a biological marker for human leukemia. (1976) (10)
Evidence for the presence of RNA tumor virus components in human leukemia. (1978) (10)
Retroviruses in human leukemia (2007) (10)
Human T-cell leukemia virus in cutaneous T-cell lymphoma in Denmark. A possible association of HTLV and aneuploidy. (1984) (10)
Discriminating between protective and enhancing HIV antibodies. (1990) (10)
Seroepidemilogy of human T‐lymphotropic retrovirus type I (HTLV‐I) in residents of niigata prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme‐linked immunosorbent assay (1985) (10)
Characterization of reverse transcriptase from filine leukemia virus by radioimmunoassay. (1979) (10)
Sarcoidosis and the human T-cell leukemia-lymphoma virus. (1983) (10)
Getting to Market: The Scientific and Legal Climate for Developing an AIDS Vaccine (1987) (10)
Enzyme Abnormality in Human Leukaemia (1968) (10)
HTLV: epidemiology and relationship to disease. (1984) (10)
Kyoto Workshop on some specific recent advances in human tumor virology. (1981) (10)
Human retroviruses with emphasis on HTLV-III/LAV: Now and future perspectives (1987) (10)
The inhibitory effect of heme on heme formation in vivo: possible mechanism for the regulation of hemoglobin synthesis. (1967) (10)
Increased susceptibility of peripheral mononuclear cells of leukemic patients to HTLV-I infection in vitro. (1987) (10)
Transfer RNA's in human leukemia (1969) (9)
Molecular studies of human T-cell leukemia virus and adult T-cell leukemia. (1984) (9)
New facts and speculations on human myeloid leukemias. (1981) (9)
Viruses and Bacteria Associated with Cancer: An Overview (2021) (9)
Characterization of a partial provirus from a gibbon ape naturally infected with gibbon ape leukemia virus. (1980) (9)
HIV-1, HHV-8, and Kaposi's sarcoma. (1998) (9)
Response: Role of β-Chemokines in Suppressing HIV Replication (1996) (9)
The transfer RNA methylases of human lymphocytes. II. Delayed induction by PHA in lymphocytes from patients with chronic lymphocytic leukemia. (1971) (9)
The first human retroviruses: are there others? (1985) (9)
HIV--the cause of AIDS: an overview on its biology, mechanisms of disease induction, and our attempts to control it. (1988) (9)
Observations on the Regulatory Effects of the Transfer RNA Minor Base, N6-Δ2-(Isopentenyl)Adenosine, on Human Lymphocytes (1971) (9)
Deoxyribonucleic acid-dependent ribonucleic acid polymerases from spleen of uninfected and Rauscher murine leukemia virus-infected NIH Swiss mice.? (1975) (9)
Human T‐Cell Lymphotropic Virus Antibody Screening: Data Survey on 33,603 German Blood Donors Correlated to Confirmatory Tests (1985) (8)
Targeting Tat and IFN(alpha) as a therapeutic AIDS vaccine. (2002) (8)
Transmission of human T-lymphotropic retrovirus infection to chimpanzees using brain and other tissues from AIDS patients (1985) (8)
Isolation, characterization, and biological effects of the first human retroviruses: the human T-lymphotropic retrovirus family. (1985) (8)
Biochemical and immunological properties of the DNA polymerase and RNAase H activities of purified feline leukemia virus reverse transcriptase. (1980) (8)
HTLV-I, the prototype human retrovirus: epidemiologic features. (1985) (8)
Use of oral polio vaccine and the incidence of COVID-19 in the world (2022) (8)
Human T-cell leukemia/lymphoma viruses: ATL and AIDS. (1985) (8)
Differential expression of the amy gene in human hematopoietic cells (8)
Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease. (1984) (8)
Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). (1985) (8)
Cellular and virological studies directed to the pathogenesis of the human myelogenous leukemias. (1979) (8)
C-C chemokine RANTES and HIV long terminal repeat-driven gene expression. (1997) (8)
Viruses and Adult Leukemia — Lymphoma of Man and Relevant Animal Models (1982) (8)
Toward a vaccine against AIDS: rationale and current progress. (1986) (8)
HTLV: the virus of adult T-cell leukaemia in Japan and elsewhere. (1982) (8)
Thymosin in the staging and treatment of HTLV-III positive homosexuals and hemophiliacs with AIDS-related immune dysfunction. (1985) (8)
Type-specific binding antibody to baboon endogenous virus (M7) reverse transcriptase. (1979) (8)
HTLV‐III Can Cross the Blood‐Brain Barrier a (1988) (8)
Attenuated poxvirus vectors as carriers in vaccines against human T cell leukemia-lymphoma virus type I. (1996) (8)
Antibodies to Human T Lymphotropic Virus Type III Demonstrated by a Dot Immunobinding Assay (1985) (8)
An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques (2016) (8)
IMMUNE T CELLS REACTIVE AGAINST HUMAN T-CELL LEUKAEMIA/LYMPHOMA VIRUS (1984) (8)
Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein. (1986) (8)
The leukotriene B 4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD 4-positive cells (1998) (7)
Kaposi's sarcoma in pregnant women (1995) (7)
ANTIBODIES TO HTLV I AND III IN SERA FROM TWO JAPANESE PATIENTS, ONE WITH POSSIBLE PRE-AIDS (1984) (7)
Tampering of Viruses and Bacteria with Host DNA Repair: Implications for Cellular Transformation (2021) (7)
Mechanisms for induction of differentiation in the human promyelocytic cell line HL-60. (1983) (7)
A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene. (1984) (7)
Isolation procedures for patients with leukemia or lymphoma associated with human T-cell leukemia virus. (1983) (7)
Monoclonal antibodies against human t cell leukemia-lymphoma virus (htlv) p25 internal core protein. (1984) (7)
Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokines. (1996) (7)
Relative activities of HIV-1-IIIB and HIV-1BaL LTR and tat in primary monocytes and lymphocytes. (1991) (7)
Evidence for HTLV‐III/LAV expression by primary cultures of T8 cells (1986) (7)
CHAPTER 4 – Leukemia, Environmental Factors, and Viruses (1978) (7)
HIV-1 expression by T8 lymphocytes after transfection. (1988) (7)
Errors in Celia Farber's March 2006 article in Harper's Magazine (2006) (7)
HIV-I replication requires an intact integrase reading frame. (1989) (7)
Human retroviruses: Cancer and aids (1989) (7)
The first human retroviruses: are there others? (1985) (7)
Uptake and aminoacylation of exogenous transfer RNA by mouse leukemia cells. (1972) (6)
Characterization of an RNA-directed DNA-polymerase from a cell line derived from a radiation-induced lymphoma in mice. (1979) (6)
Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro. (1987) (6)
RISK OF INFECTION OF LABORATORY WORKERS WITH THE HUMAN T-CELL LEUKAEMIA VIRUS (1983) (6)
Placenta-bound immunoglobulins. (1979) (6)
Human tumor and immunodeficiency viruses. (1987) (6)
Synthesis of type‐C virus particles from murine cultured cells induced by iododeoxyuridine. VI. Biosynthesis of reverse transcriptase (1977) (6)
Growth of human normal and leukemic T cells: T-cell growth factor (TCGF) and the isolation of a new class of RNA tumor viruses (HTLV). (1981) (6)
IMMUNE FUNCTIONS IN HTLV-III ANTIBODY POSITIVE HOMOSEXUAL MEN WITHOUT CLINICAL AIDS (1984) (6)
Transfer RNA methylases and transfer RNA-methylated bases of polyoma virus-transformed and spontaneously transformed mouse culture cells. (1973) (6)
Human T-lymphotropic virus type III (HTLV-III). (1987) (6)
On the origin of human acute myeloblastic leukemia: virus-"hot spot" hypothesis. (1974) (6)
Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS. (1984) (6)
A recombinant clone of HIV-1 preferentially transmitted in normal peripheral blood mononuclear cells. (1989) (6)
Natural antibodies in sera from Japanese individuals infected with HTLV- I do not recognize HTLV-III (1985) (6)
Simple affinity procedure for the purification of mammalian viral reverse transcriptases (1980) (6)
Human T-Cell Retrovirus and Adult T-Cell Lymphoma and Leukemia: Possible Factors on Viral Incidence (1983) (6)
Summary of recent observations on the molecular biology of RNA tumor viruses and attempts at application to human leukemia. (1973) (6)
Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesion molecules in cervical endothelial cells but not in human umbilical vein endothelial cells. (2001) (6)
HTLV-III legend correction. (1986) (6)
Aminoacyl transfer RNA profiles in human myeloma cells. (1971) (6)
Lack of expression of cellular homologues of retroviral onc genes in bovine tumors. (1983) (6)
HIV encephalopathy and lymphadenopathy: cells associated with viral antigens. (1989) (6)
Familial chronic discoid lupus erythematosus and hypergammaglobulinemia. (1966) (6)
Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infection. (1987) (6)
Human T-cell growth factor (TCGF). (1984) (6)
Production of linear polymers of HIV gp120-binding domains. (1994) (6)
Humanization of an antibody recognizing a breast cancer specific epitope by CDR-grafting. (1997) (6)
Are viruses concerned in the etiology of human leukemia (1974) (5)
Rearrangement and enhanced expression of c-myc oncogene in fresh tumor cells obtained from a patient with acute lymphoblastic leukemia. (1986) (5)
Advances in the viral etiology of leukemia and lymphoma. (1978) (5)
Restricted expression of integrated primate type-C virus (gibbon ape leukemia virus-simian sarcoma virus) proviral DNA in nonproductively infected human B lymphoblasts. (1982) (5)
Proliferative T‐Cell Response to HIV Envelope Glycoprotein in Immunized and Infected Primates and Human Beings (1989) (5)
HIV/AIDS Research for the Future. (2020) (5)
A Plea for Justice for Jailed Medical Workers (2006) (5)
CONCEPTS ON THE INTERFERENCE OF REPLICATION AND EXPRESSION OF RNA TUMOR VIRUSES (1977) (5)
Developing a Successful HIV Vaccine. (2015) (5)
A comparative evaluation of methods for isolation of RNA-directed DNA polymerase from cells in a reconstituted system. (1976) (5)
Lymphotropic retroviruses of animals and man. (1988) (5)
Differential viral gene expression and its effect on the biological properties of the cell clones of an HIV-1-infected cell line. (1990) (5)
Tumor viruses at Cold Spring Harbor. (1974) (5)
Tumorigenesis and metastasis of neoplastic Kaposiá¤™s sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone (1995) (5)
The path to the discoveries of human retroviruses. (2000) (5)
A perspective on human herpes virus 6 (HHV-6). (2006) (5)
Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS. (1984) (5)
RNA tumor viruses and leukemia: evaluation of present results supporting their presence in human leukemias. (1976) (5)
Structure of the long terminal repeat of simian lymphotropic virus type III (African green monkey) and its relatedness to that of HIV. (1987) (5)
Blattner and Colleagues Respond to Duesberg (1988) (5)
Oncogenic RNA viruses. (1976) (5)
In vitro characterization of a biologically active molecular clone of HIV-2NIH-Z containing a nef deletion and expressing a full-length transmembrane protein. (1990) (5)
A model scheme for human hematopoietic cell differentiation as determined by multiple markers of leukemia-lymphomas. (1983) (5)
Establishment of an etiologic relationship between the human T-cell leukemia/lymphoma virus (HTLV) and adult T-cell leukemia (1983) (5)
Enforced expression of human bcl‐2 in CD4+ T cells enhances human herpesvirus 7 replication and induction of cytopathic effects (1998) (5)
HIV receptors on lymphocytes (2003) (5)
Assessment of angiogenic potential--the use of AIDS-KS cell supernatants as an in vitro model. (1992) (5)
F-103 A conformational switch that turns on the B cell growth- promoting activity of the HIV-1 matrix protein p17 (2016) (4)
Human T-cell leukemia/lymphoma viruses: ATL and AIDS. (1985) (4)
HIV-1 Tat protein enhances angiogenesis and Kaposi's sarcoma (KS) development triggered by inflammatory cytokines (IC) or bFGF by engaging theαvβ3 integrin: 68 (1997) (4)
CORRELATION BETWEEN EXPOSURE TO HUMAN: T‐CELL LEUKEMIA‐LYMPHOMA VIRUS‐III AND THE DEVELOPMENT OF AIDS a (1984) (4)
On the origin of human acute myeloblastic leukemia: virus-"hot spot" hypothesis. (1974) (4)
Recent studies with infectious primate retroviruses: hybridization to primate DNA and some biological effects on fresh human blood leukocytes by simian sarcoma virus and gibbon ape leukemia virus. (1980) (4)
Human T-lymphotropic retroviruses in adult T-cell leukemia-lymphoma and acquired immune deficiency syndrome (1984) (4)
Comparison of chromatographic patterns of low molecular weight RNA from Burkitt lymphoma, infectious mononucleosis, EB-virus transformed, and normal human lymphoblasts. (1972) (4)
A Human T-Lymphotropic Retrovirus (HTLV-III) as the Cause of the Acquired Immunodeficiency Syndrome (1986) (4)
COVID-19: A Paradigm Change (2020) (4)
Human T-lymphotropic virus type III (HTLV-III). (1987) (4)
Human Retroviruses: HTLV‐I, II, and III and Their Association with Leukemia and AIDS (1987) (4)
[HTLV-I retroviral variant in Zaire in patient with chronic neuromyelopathy. Nucleotidic sequence of the envelope gene]. (1992) (4)
Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs. (1985) (4)
On the Evidence for Type-C RNA Tumor Virus Information and Virus-Related Reverse Transcriptase in Animals and in Human Leukemia Cells (1975) (4)
Viruses and the pathogenesis of human leukemia. (1977) (4)
Interaction of HBLV (HHV-6) With EBV and HIV (1989) (4)
Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1. (1989) (4)
HTLV-III/LAV and the origin and pathogenesis of AIDS. (1987) (4)
Proteome analysis of Mycoplasma fermentans cultured under aerobic and anaerobic conditions (2019) (4)
Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein. (1987) (4)
The Interaction of Human T-Cell Growth Factor with Normal and Neoplastic T Cells (1982) (4)
Biochemical properties of reverse transcriptase activities from human cells and RNA tumor viruses. (1973) (4)
Advances in the viral etiology of leukemia and lymphoma. (1978) (4)
Molecular probes for tumor viruses in human cancer. (1976) (4)
The human T-cell leukemia-lymphoma virus family. (1985) (4)
Adrenal Corticosteroids EnhanceProduction ofType-C VirusInduced (1973) (4)
New concepts for future control of HIV derived from studies of pathogenesis. (2000) (4)
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin (2020) (4)
Origins of human T-lymphotropic viruses [letter] (1986) (4)
Detection of integrated type-C viral DNA fragments in two primates (human and gibbon) by the restriction enzyme blotting technique. (1979) (4)
Gallo's virus sequence (1991) (4)
Human T-cell growth factor (TCGF). (1984) (3)
220 Novel Functional mAbs Against HIV-1 Gp120 from HIV Controller (2011) (3)
Restricted expression of retrovirus nucleic acids and proteins in primate type C virus (gibbon ape leukemia virus-simian sarcoma virus)-initiated human B-lymphoblast cultures. (1981) (3)
Epilogue: a journey with blood cells and viruses. (2002) (3)
Sequential changes in antibody levels to the ENV and GAG Antigens in human immunodeficiency virus infected subjects (1987) (3)
HIV-1: a look back from 20 years. (2004) (3)
The Origin of RNA Tumor Viruses and Their Relation to Human Leukemia (1977) (3)
Therapeutic vaccine to control stromal tumor-induced immunosuppression in human uterine cervixc cancer. (2003) (3)
Commentary on “Prevalence and evolution of drug resistance HIV-1 variants in Henan, China” (2005) (3)
Comparison of biochemical characteristics of reverse transcriptase from human acute leukemic cells and several RNA tumor viruses. (1974) (3)
Human trophoblasts: cellular source of colony-stimulating activity in placental tissue. (1982) (3)
Monoclonals and DNA probes in diagnostic and preventative medicine (1987) (3)
Heteroduplex mapping in the molecular analysis of the human T-cell leukemia (lymphotropic) viruses. (1985) (3)
The phenotypic abnormality in leukemia: a defective cell-factor interaction? (1976) (3)
Nucleotide Sequence Analysis of a Variant Human T-Cell Leukemia Virus ( HTLV-Ib ) Provirus with a Deletion in pXI (3)
Retroviruses of human T cells: their role in the aetiology of adult T-cell leukaemia/lymphoma and the acquired immune deficiency syndrome. (1985) (3)
Reverse transcriptase and neoplasia. (1973) (3)
Clinical Correlates of Retroviral Serology in Nigerians (1988) (3)
Posttranscriptional effect of dexamethasone and interferon on the viral replication induced by iododeoxyuridine from murine transformed by nonproducer fibroblasts. (1976) (3)
Nucleotide Sequence Analysis of a Variant Human T-Cell Leukemia Virus ( HTLV-Ib ) Provirus with a Deletion in pXI (3)
Prevention of hypogammaglobulinemia of prematurity with intravenous immune globulin. (1990) (3)
New concepts on human myelogenous leukemia based on studies of the simian RNA tumor virus family. (1975) (3)
Cloning and characterization of different human sequences related to the onc gene ( v-myc ) of avian myelocytomatosis virus ( MC 29 ) ( type C RNA tumor virus / onc genes ) (2003) (3)
Response: Role of beta-Chemokines in Suppressing HIV Replication. (1996) (3)
Human "T" leukemia virus still suspected in AIDS. Interview by John Maurice. (1983) (3)
Studies in Human Hematopoietic Cells: Cellular and Virological Aspects (1979) (3)
Thematic review series. XI: Viruses in the origin of human cancer. Introduction and overview. (1999) (3)
NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. (1989) (3)
Human T-cell leukemia (lymphotropic) retroviruses and their causative role in T-cell malignancies and acquired immune deficiency syndrome. (1985) (3)
Modulating the durability of anti-HIV gp120 antibody responses after vaccination: a comment on Wilson & Karp (2015) (2015) (3)
Natural antibodies in sera from Japanese individuals infected with HTLV-I do not recognize HTLV-III. (1985) (3)
Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A (2006) (3)
Clinical and immunological findings in HTLV-III infection. (1985) (3)
25 years after discovering HIV as the cause of aids: prospects for a vaccine (2010) (3)
350 HTLV III/LAV antibodies in pediatric acquired immune deficiency syndrome (AIDS) (1985) (2)
HBZ RNA may promote cell survival against clastogenic damages and thereby contributes to the development of leukemic ATL cells (2014) (2)
Lymphokines released by activated or HTLV-infected T cells induce growth of normal mesenchymal cells and of cells derived from Kaposi’s sarcoma lesions of AIDS patients. (1991) (2)
OBITUARY: Howard M. Temin (1934–94) (1994) (2)
Interference with formation and expression of RNA tumor virus information: rationale and experimental results. (1974) (2)
Transmission of human T-cell leukemia virus (HTLV) into human cord blood T cells. (1983) (2)
Enrichment of cell populations containing terminal deoxynucleotidyl transferase activity by free flow electrophoresis (1982) (2)
Human T-cell leukemia-lymphoma virus (HTLV): a progress report. (1983) (2)
Immune response to immunostimulatory complexes prepared from human immunodeficiency virus and the external envelope glycoprotein (1989) (2)
Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study (2006) (2)
Cell-Factor Interaction in Populations of Normal and Leukemic Blood Cells (1977) (2)
Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions (1986) (2)
Detection of human T‐cell leukemia virus antibodies in a Japanese T‐cell leukemia patient with hypercalcemia (1984) (2)
Enforced expression of human bcl-2 in CD4+ T cells enhances human herpesvirus 7 replication and induction of cytopathic effects. (1998) (2)
The virus-cancer story. (1983) (2)
Variability of CD4+ cell counts in HIV-1 uninfected volunteers who are eligible for a Phase I HIV vaccine study. (2020) (2)
A classification of HTLV-III infection based on 75 cases seen in a suburban community. (1985) (2)
Human T-Cell Growth Factor, Growth of Human Neoplastic T Cells, and Human T-Cell Leukemia-Lymphoma Virus (1984) (2)
AIDS and Related Malignancies (1992) (2)
Prospects for biologic and pharmacologic inhibition of ribonucleic acid tumor viruses. (1976) (2)
T cell proliferation and human T cell leukemia virus (HTLV). (1983) (2)
Partial envelope sequences from some of the earliest isolates of HIV-1. (1994) (2)
Some recent results on HIV pathogenesis with implications for therapy and vaccines. (2001) (2)
Concluding Remarks: Human and Related Viruses of Leukemia, Lymphoma, and Immunodeficiency: Biology, Pathogenesis, Treatment, and Prevention (1990) (2)
Transcription of heteropolymeric regions of avian myeloblastosis virus high molecular weight RNA with Escherichia coli DNA polymerase I. (1974) (2)
Inhibition by RNA of RNase H Activity Associated with Reverse Transcriptase in Rauscher Murine Leukemia Virus Cores (1978) (2)
Epidemiology of HTLV-associated leukemia. (1983) (2)
DNA-direced and RNA-primed DNA synthesis in microsomal and mitochondrial fractions of normal human lymphocytes. (1974) (2)
Hiv 1 tat protein released during acute infection stimulates growth of spindle cells derived from aids kaposis sarcoma (1990) (2)
Analysis of DnaK Expression from a Strain of Mycoplasma fermentans in Infected HCT116 Human Colon Carcinoma Cells (2021) (2)
Characterization by Nucleic Acid Hybridization of HTLV, a Novel Retrovirus from Human Neoplastic T-Lymphocytes (1981) (2)
Modern Trends in Human Leukemia IX (1992) (2)
Infectious primate type C virus proviral DNA in productively infected cells (1978) (2)
LAV/HTLV-III: fine-structure analysis, localization of structural proteins, and detection of envelope antigens by patient sera. (1987) (2)
A biochemical variant of T-cell growth factor (TCGF) produced by a cutaneous T-cell lymphoma cell line☆☆☆ (1982) (2)
Molecular Biology of HTLV (1984) (2)
Toward an HIV preventive vaccine: problems and prospects (2009) (2)
Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals. (1985) (2)
. . . and his response (1991) (2)
Novel biologic approaches for the treatment of AIDS. (1999) (2)
Evaluation of anti-tumor agents on tRNA methylase activity of leukemia L1210. (1972) (2)
Exogenous bacterial DnaK increases protein kinases activity in human cancer cell lines (2021) (2)
162a Update on Kinoids as an Active Immunotherapy to Combat Pathogenic Cytokines in Viral, Cancer and Autoimmune Diseases: Safety, Immunogenicty (2011) (1)
171 – Human Immunodeficiency Viruses (2015) (1)
New approaches to HIV treatment: interview with Robert Gallo. M.D. Interview by John S. James. (1997) (1)
A-110 Special panel discussion on HIV cure research (2017) (1)
Reverse transcriptase in acute leukaemia. (1974) (1)
Kaposi's sarcoma, vascular permeability, and scientific integrity. (1994) (1)
Some reflections on HIV/AIDS Research After 40 years. (2021) (1)
HIV's leading men. (2011) (1)
HIV/AIDS research after HAART. (2005) (1)
Some novel approaches to the control of HIV and select aspects of HIV pathogenesis. (1996) (1)
The world of HIV and disease, and some new approaches to block it. (1998) (1)
HTLV-III and the Etiology of AIDS (Part 2 of 2) (1986) (1)
A personal perspective on HIV-AIDS research. (1999) (1)
Human retroviruses and herpes viruses: their role in immune dysfunctions and neoplasia. (1988) (1)
T cell malignancies and human T cell leukemia (lymphotropic) retroviruses (HTLV). (1985) (1)
New approaches to HIV treatment: interview with Robert Gallo. M.D. Interview by John S. James. (1997) (1)
Personal reflections on the origin of human leukemia. (1987) (1)
Infection of the Central Nervous System by Human Retroviruses (1994) (1)
The human T-cell leukemia/lymphotropic viruses: recent developments. (1986) (1)
The mechanism of asparaginase resistance of leukemic cells, correla- tions with alterations in asparaginyl-transfer rna. Abstr. (1970) (1)
Detection of rare cells expressing HTLV-III in primary lymphoid tissue from infected individuals using a highly sensitive in situ hybridization method (1986) (1)
Prospects for Development of a Vaccine Against HTLV-III Disease (1986) (1)
Natural antibodies to simian type-C viruses and human retrovirus HTLV in patients with lymphoid malignancies. (1984) (1)
Non-toxic immunogens for therapeutic anticytokine vaccines. (2001) (1)
HHV-8-LIKE VIRUS CAN INFECT CYNOMOLGUS MONKEYS (1999) (1)
Molecular cloning and analysis of different human t lymphotropic retroviruses from patients with acquired immune deficiency syndrome or t cell malignancy (1984) (1)
Inhibition of HIV-1 Infection by the b-Chemokine MDC (2016) (1)
Biochemical approaches to detection of viral related information in human acute leukemic cells. (1975) (1)
High prevalence of human herpes virus 6 DNA in Hodgkin's disease: a study by in situ hybridization and polymerase chain reaction (1995) (1)
New facts and speculations on human myeloid leukemias. (1981) (1)
Monocytoid Cells Chemokine Receptors CCR 1 and CCR 3 in Expression of Apoptosis Receptor CD 95 and ( 2 b ) Increases the α Recombinant IFN-Gallo (1999) (1)
A rapid and sensitive assay for proviral sequences of a human retrovirus (HTLV) in leukemic cells. (1983) (1)
Reverse transcriptase. (1975) (1)
Recombinant virus coat protein associated with "Acquired Immune Deficiency Syndrome" (AIDS), and methods for testing of AIDS. (1986) (1)
Both Resting and CD 3-Stimulated CD 4 Chemokine Receptor 4 Surface Expression in Engagement of CD 28 Modulates CXC (2000) (1)
A historical personal perspective on human retroviruses and their infection of T cells (2015) (1)
B cell lymphoma in hiv transgenic mice (2013) (1)
Human retroviruses and herpes viruses: their role in immune dysfunctions and neoplasia. (1988) (1)
T-cell leukemia/lymphoma The human T-cell leukemia/lymphoma virus associated with American adult (2011) (1)
Glucocorticosteroids and RNA tumor viruses. (1974) (1)
Proteins Encoded by the Human T-Lymphotropic Virus Type III/ Lymphadenopathy Associated Virus (HTLV-III/LAV) Genes (1986) (1)
Presence of HTLV in a subset of T cells from an infected patient: some immunochemical properties of the infected cells. (1983) (1)
Detection of a surface antigen on NIH3T3 cells transfected with a human leukemia oncogene (1985) (1)
Purification of normal human T-cell growth factor to molecular homogeneity. (1985) (1)
In vitro transformation of human cord blood and bone marrow T lymphocytes by HTLV. (1984) (1)
HIV Coreceptors and Chemokines as Therapeutic Targets Against HIV/AIDS (2001) (1)
Evolutionary nature of human reverse transcriptase and of viral-related DNA synthesized in vitro by human leukemic cells. (1975) (1)
Activated peripheral blood lymphocytes produce factors promoting the growth of spindle cells derived from AIDS-associated Kaposi’s sarcoma. (1990) (1)
RNA Tumor Virus and Reverse Transcriptase (1973) (1)
Vaccine Strategies against the Human Retroviruses Associated with AIDS (1986) (1)
The Rgd Motif And The Integrin Receptors Are Involved In The Vascular Cell Growth And Adhesion Properties Of Extracellular Hiv-1 Tat Protein (1993) (1)
Retroviruses and human pathology (1987) (1)
[Kinoids: a novel generation of specific immune therapy against cytokines]. (2008) (1)
Etiology of AIDS: biological and biochemical characteristics of HTLV-III. (1985) (1)
Molecular epidemiology of htlv i in the world identification of novel htlv i variants in africa and melanesia (1992) (1)
RNA tumor virus and reverse transcriptase. I. Biochemical studies on the ESP-1 particles. II. Role of the reverse transcriptase in murine RNA tumor virus. (1973) (1)
Human T-cell growth factor and control of T-cell proliferation (1983) (1)
Reply to “Anti-KS activity still a mystery” (1998) (1)
Hemopoietic stem cells and leukemia. (1974) (1)
T cell function in myelogenous leukemia. (1979) (1)
Cellular transformation by human T cell leukemia retroviruses (HTLV). (1985) (1)
221 Humoral Immunity against Conserved Epitopes of HIV-1 Envelope Protein Archived in Memory B cells in Natural Viral Suppressors: Discordance with Plasma Antibodies (2009) (1)
Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome. (1985) (1)
A journey with T cells, primate/human retroviruses and other persisting human T-cell tropic viruses. (2003) (1)
Human T-cell leukemia-lymphoma virus ( HTLV ) : Cloning of an integrated defective provirus and flanking cellular sequences ( human type C retrovirus / T-cell leukemia / molecular cloning / integrated provirus ) (1)
Human Herpesvirus-6 (Human B-Lymphotrophic Virus) (1989) (1)
Cytopathogenic Mechanisms Which Lead to Cell Death of HTLV III Infected T Cells (1986) (1)
INCREASED HUMAN HERPESVIRUS-8 COPY NUMBER AND VIRAL GENE EXPRESSION IN AIDS-KAPOSI'S SARCOMA PATIENTS PERIPHERAL BLOOD MONONUCLEAR CELLS CULTURED IN PRESENCE OF INFLAMMATORY CYTOKINES. (1998) (1)
The Great Coronavirus Pandemic of 2019−2021: the Future and the Requirement for China-America Cooperation (2021) (1)
HIV: dark and light, then and now (2006) (1)
Primate type-C virus-related reverse transcriptase and RNA in human acute leukemia cells as potential diagnostic markers. (1974) (1)
helper A Nonenzymatic RNA Polymerase Model (2005) (1)
Response: Factor XIIIa--Expressing Dermal Dendrocytes in AIDS-Associated Cutaneous Kaposi's Sarcomas. (1989) (1)
An overview of the human T-lymphotropic retroviruses and the role of HTLV-III/LAV in AIDS. (1987) (1)
Cancer viruses. (1972) (1)
Human Retroviruses in the Second Decade: Some Pathogenic Mechanisms and Approaches to Their Control (1995) (1)
Are viruses concerned in the etiology of human leukemia? (1974) (1)
T cell proliferation and human T cell leukemia virus (HTLV). (1983) (1)
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial (2021) (1)
Biochemical Markers for Human Leukemia and Cell Differentiation (1983) (1)
Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-κB inhibition (2014) (1)
Cellular onc genes: their role as progenitors of viral onc genes and their expression in human cells. (1983) (1)
Human T-cell leukemia-lymphoma virus (HTLV) and human viral onc gene homologues. (1983) (1)
Differential susceptibility of human mononuclear cells to infection with HTLV-I. (1987) (1)
Letter to the Editor (2021) (1)
Choosing the Right Path toward Polio Eradication. (2023) (1)
The dual (activating/suppressive) effect of extracellular TatHIV-1 is driven by the infalmmatory microenvironment of infected lymphoid foci (2012) (1)
A method and cell line for the continuous formation of the retrovirus (HTLV-III) related to AIDS (1985) (0)
A New Monoclonal Antibody, mAb 4A12, Identiﬁes a Role for the Glycosaminoglycan (GAG) Binding Domain of RANTES in the Antiviral Effect against HIV-1 and Intracellular Ca 2 (cid:49) Signaling (1998) (0)
Strong HIV-1 inhibitory activity by antisense phosphorothioate oligonucleotides targeted to HIV-1 untranslated leader sequences (1995) (0)
Human T-cell leukemia-lymphoma -integrated defective provirus and f) (human type C retrovirus/T-cell leukemia/molecular cloning/integi (2016) (0)
Retroviral Transfer of Human Mutated Thymidylate Synthase Gene into Hematopoietic Stem Cells for Protection from High-Dose Fluoropyrimidine Toxicity (2001) (0)
Chapter Four – Viruses and Cancer (1980) (0)
Characterization of the interactome profiling of Mycoplasma fermentans DnaK in cancer cells reveals interference with key cellular pathways (2022) (0)
162 Active Anti-IFN α Immunotherapy Applied to Chronic Viral and Autoimmune Diseases (2011) (0)
Faculty Opinions recommendation of Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. (2019) (0)
Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human (2016) (0)
Follow-up of HIV Infected Patients Who Received a Therapeutic Anti-Tat Vaccination (2005) (0)
D-108 Vaccination Strategies to Safely Elicit Long-Lived Humoral Responses against HIV gp120 (2014) (0)
[A simple method for determination of antibodies to AIDS associated virus (HTLV-III)]. (1984) (0)
HIV prevention by vaccine (2012) (0)
The Global Virus Network’s testimony on Ebola to the U.S. Senate (2014) (0)
ANIMAL MODELS OF NEOPLASMS IN ACQUIRED IMMUNODEFICIENCY (1999) (0)
Immune stimulation and HIV-1 infection have complementary effects in the induction and progression of AIDS-associated Kaposi’s sarcoma via release of cytokines and Tat. (1991) (0)
Structural proteins of HTLV-III/LAV (1987) (0)
Reflections on Some of the Exceptional Features of HTLV-1 and HTLV-1 Research: A Perspective (2022) (0)
A method for isolating HTLV-III proteins, serological detection of antibodies to HTLV-III in the serum of AIDS and pre-AIDS patients and detection of HTLV-III infection in immunoassays and test system for use in the method (1985) (0)
Enrichment of terminal deoxynucleotidyl transferase activity by cell separation. (1982) (0)
200 The β Chemokines MDC, TARC and I-309 are an Important Component of the Soluble anti-X4 Activity Secreted by CD4+ and CD8+ T Cells (2011) (0)
Oncogenic viruses: Third edition, by Ludwik Gross (Pergamon Press, 1983) (1984) (0)
Leukemia-Lymphoma Virus ( HTLV ) : A Progress Report (2005) (0)
Faculty Opinions recommendation of Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis. (2019) (0)
Faculty Opinions recommendation of Whole body clonality analysis in an aggressive STLV-1 associated leukemia (ATLL) reveals an unexpected clonal complexity. (2019) (0)
Human Acute Leukemia: Increasing Evidence for Involvement of Type-C Rna Tumor Viruses (1975) (0)
Stimulatory and inhibitory influences of human immunodeficiency virus* on normal B lymphocytes (retrovirus/immunomodulation/polyclonal B-cell activation/immunoglobulin secretion/T-lymphocyte suppression) (0)
Comparison of drug effects on RNA tumor viruses and on transformed cells. (1975) (0)
Production d'interleukine 2 (IL2) par les lymphocytes T humains en culture de sujets zaïrois (1986) (0)
Functional and morphologic characterization of human T cells continuously grown in vitro. J. Immunol. 1977. 119: 131-138. (2007) (0)
Interfering with HIV-1 replication by affecting cellular factors. HIV-1 inhibition by hydroxyurea (1995) (0)
HHV-6 and CMV pneumonitis in immunocompromised patients. (1994) (0)
Howard M. Temin (1934-94) (1994) (0)
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma ( mycosis fungoides / T-cell growth factor / RNA tumor virus / reverse transcriptase ) (0)
112 Diversity of Specificity and Function Among Human Antibodies to Transitional Epitopes Altered by CD4 Binding to the HIV-1 Env Glycoprotein (2012) (0)
P-D8 Targeting of the catalytic site of host mTOR controls HIV in vivo: (2016) (0)
Role of HIV-1 TAT gene product and of cytokines released by activated immune cells in the pathogenesis of AIDS-associated Kaposi’s sarcoma. (1991) (0)
Immunology of human T-cell leukemia/lymphoma (lymphotropic) viruses (the HTLV ‘family’) (1986) (0)
The Cloning and Analyses of Human Cellular Genes Homologous to Retroviral Onc Genes (1983) (0)
The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages ( nef gene / macrophage infection ) (0)
Immunoactivation Rather Than Immunodeficiency May Cooperate With Hiv - 1 Infection In The Development Of Aids-associated Kaposi's Sarcoma (1993) (0)
Introduction for P.H. Duesberg (1985) (0)
Retroviruses in human T-cell malignancies. (1984) (0)
Life cycle of RNA oncogenic viruses. (1974) (0)
A New Simian Herpesvirus Closely Related To Ebv Contributes Substantially To The Establishment Of B-cell Lymphoma In Immunodeficient Cynomolgus Monkeys (1993) (0)
Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1 (2020) (0)
Faculty Opinions recommendation of Can we reduce the incidence of adult T-cell leukaemia/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom. (2019) (0)
The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1 (2005) (0)
A brief history of AIDS (2006) (0)
Cell strain for continuous production of retrovirus (htlv-iii) related to aids (1993) (0)
P-A6 Expression of HIV-1 matrix protein p17 and correlation with B cell lymphoma in HIV-1 transgenic mice (2017) (0)
A T lymphocyte-derived differentiation-inducing factor for myeloid leukemia cells: purification and characterization. (1985) (0)
Cc chemokine that prevent infection with viruses reto (1996) (0)
International Symposium: Retroviruses and Human Pathology (1986) (0)
Faculty Opinions recommendation of Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs. (2019) (0)
Human T-Cell Lymphotropic Retroviruses (HTLV) Associated with T-Cell Malignancy and Immunodeficiency: In Vitro Studies (1985) (0)
Faculty Opinions recommendation of Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). (2019) (0)
Human T-lymphocyte growth factor: regulation of growth and function of T (2010) (0)
F-106 Transition state Gp120 structures as HIV vaccines (2016) (0)
Clues to finding correlates of risk / protection for HIV-1 vaccines (2017) (0)
210 Peripheral blood mononuclear cells activated by HIV-VLPs in correlation with HIV-1 seropositivity status (2009) (0)
Roles of HTLV-I p19 and natural antibody to HTLV-I in host immune responses. (1985) (0)
Peripheral Nerve Degeneration in the HIV-1 Transgenic Rat (2001) (0)
Integrin-mediated uptake of HIV-1 Tat protein by cytokine-activated endothelial cells. (1994) (0)
V-2 Nov 95 (0)
Retroviruses and Onc Genes in Human Leukemias and Lymphomas (1985) (0)
Faculty Opinions recommendation of Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians. (2019) (0)
Human T-Cell Leukemia (Lymphotropic) Retroviruses: The HTLV Family and their Role in Leukemias, Lymphomas and AIDS (1985) (0)
Methylation of transfer RNA by monkey liver and hepatoma induced by N-nitrosodiethylamine. (1971) (0)
The dual (activating/suppressive) effect of extracellular TatHIV-1 is driven by the infalmmatory microenvironment of infected lymphoid foci (2012) (0)
Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media ( lymphokines / blast transformation / cultured T cells / colony-stimulating activity ) (0)
patients to HTLV-I infection in vitro Increased susceptibility of peripheral mononuclear cells of leukemic (2012) (0)
Response Interleukin-15 as an Activator of Natural Killer Cell-Mediated Antiviral (2013) (0)
A comparison of the genetic and biologic features of human and non-human immunodeficiency lentiviruses. (1991) (0)
Relatedness of RNA and reverse transcriptase from human acute myelogenous leukemia cells and from RNA tumor viruses. (1974) (0)
Dispensable RoleoftheHumanImmunodeficiency VirusType2 VpxProtein inViral Replication (1991) (0)
Anti-inflammatory effects of H2S during acute bacterial infection: a review (2017) (0)
Reply to: Lack of evidence for involvement of known human retroviruses in multiple sclerosis (1986) (0)
Mechanism of leukemogenesis by human T-cell leukemia virus types I and II: role of the lor gene. (1987) (0)
128 Suppression of CCR5 Density as a Novel Way to Enhance the Anti-HIV Activity of Fusion Inhibitors and CCR5 Antagonists (2011) (0)
T-CELLS: cDNA CLONING AND CHARACTERIZATION (1984) (0)
HIV and the Pathogenesis of AIDS: by Jay A. Levy ASM Press, 1994. £29.50 pbk (xiv + 359 pages) ISBN 1 55581 076 4 (1995) (0)
Modesoftransmission andevidence forviral latency fromstudies ofhumanT-cell lymphotrophic virus typeIinJapanese migrant populations inHawaii (1986) (0)
The Family of Human T-Cell Leukemia Viruses and Their Role in the Cause of T-Cell Leukemia and AIDS (1985) (0)
Release And Angiogenic Properties Of Extracellular Hiv-1 Tat Protein (1993) (0)
13 – Molecular Mechanisms of Pathogenesis by HTLV-III (1987) (0)
Africa and the origin of AIDS. (1985) (0)
P-B7 Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection (2016) (0)
Sequential HTLV-III antibody studies in danish homosexual men (2004) (0)
Medicine as a frontier: the foreign multipathological patient (2015) (0)
Lack of Sequence Homology Between the 70S RNA of Various RNA Tumor Viruses and the DNA of Simian Virus 40 or Polyoma Virus (1973) (0)
New developments: a look to the future. (1996) (0)
Recent advances in cancer research : cell biology, molecular biology, and tumor virology (1977) (0)
Retroviruses of human T cells: their role in the aetiology of adult T-cell leukaemia/lymphoma and the acquired immune deficiency syndrome. (1985) (0)
Classification of HHV-6A and HHV-6B as distinct viruses (2013) (0)
Induce Ex Vivo T-Cell Responses Particles Activate Dendritic Cells and Immunodeficiency Virus Type 1 Virus-Like Baculovirus-Derived Human (2006) (0)
The ethnic distribution of HTLV-I and HTLV-III associated diseases in Trinidad West Indies [abstract] (1985) (0)
RNA-Directed DNA Polymerase from Hun Primate Type-C Virus-Producing Cells: Hi with Variant Biochemical and Immunolog (human myelogenous leukemia/gibbon ape leukemia vil (2016) (0)
Times , They are a-Changing The outcome of the US elections in the fall of 2002 (0)
Human Retroviruses and Anti-Viral Therapies (1988) (0)
In Reply: Pseudotypes in HIV-Infected Mice. (1990) (0)
Th-1 cytokine profile in PBMC and tumor infiltrating lymphocytes (TIL) of HHV-8+ Kaposi's sarcoma (KS) patients: role of γIFN in KS development (an immune response to HHV-8 ?) (1997) (0)
A global virus network and a perspective on viral infections in humans (2012) (0)
Exogenous bacterial DnaK increases protein kinases activity in human cancer cell lines (2021) (0)
P-B32 cGMP production, characterization, and formulation of IHV01 drug product, the Full Length Single Chain gp120- CD4 (FLSC) chimera formulated in Aluminum Phosphate (2016) (0)
187 Autoresistance to X4 HIV Infection by soluble suppressor factors secreted from CD4+ T cells (2009) (0)
Polyadenylation of 35S RNA in vitro by a cytoplasmic particulate fraction from mouse myeloma. (1976) (0)
HIV prevention by vaccine (2012) (0)
Traitement et prevention de cancers par l'administration de derives de gonadotrophine chorionique humaine (1997) (0)
Proceedings: Distribution of the RNA dependent DNA polymerase in human acute leukemic cells. (1972) (0)
Cloning of Human Oncogenes (1985) (0)
Structure and Function of the Human Retroviruses (1986) (0)
Identification oftheHumanHerpesvirus 6Glycoprotein H andPutative LargeTegument Protein Genes (1991) (0)
E106 Diversity of Antibody Germline Gene and HIV-1 Infection: Implication for HIV-1 Vaccine (2013) (0)
Anti-KS activity still a mystery [3] (multiple letters) (1998) (0)
Opportunistic pricing: a new scourge, a new call for action. (1998) (0)
Structure and Function of the Genome of HTLV-III and Related Viruses: Current Concepts on the Role of HTLV-III in the Pathogenesis of Aids (1987) (0)
Isolation of HTLV-III proteins, serological determination of HTLV-III antibodies in sera from patients with AIDS and pre-AIDS conditions, and determination of HTLV-III infection by immunoassay methods using HTLV-III and its proteins. (1985) (0)
Evidence for Hiv1 Tat Receptor Expression in Kaposi Sarcoma (ks) Cell Strains and Ks Cell Line (1993) (0)
Rolf Neth (October 6, 1926 to March 17, 2020) (2020) (0)
Immunological characterization of the natural antibodies to human T-cell leukemia virus in human sera. (1983) (0)
The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1 (2005) (0)
Detection of viral genomes in lymphomas arising Sjogren's syndrome (1989) (0)
Human T-Cell Leukemia Viruses, T-Cell Leukemia and Aids (1985) (0)
Human T-Lymphotropic Retroviruses and Their Role in Human Diseases (1986) (0)
Publisher Correction: Rolf Neth (October 6, 1926–March 17, 2020) (2021) (0)
The Human T Lymphotropic Retroviruses and Human Immune Deficiency (1986) (0)
(onc genes/RNA gel blotting/avian myeloblastosis virus/hematopoie promyelocytic leukemia cell line) (2016) (0)
HIV, HTLV and Cancer (2000) (0)
SHORT COMMUNICATION Characterization of a Chemokine Receptor-Related Gene in Human Herpesvirus 8 and Its Expression in Kaposi's Sarcoma (1997) (0)
Human T Lymphotropic Retroviruses: Pathological Consequences of Infection (1990) (0)
Kaposi's Sarcoma: Correction (1999) (0)
Test method for the human b-lymphotropic virus (HBLV). (1987) (0)
The angiogenic properties of HIV-I Tat protein are mediated by two different domains. (1994) (0)
Compositions for increasing the efficiency of vaccines using chemokines (1998) (0)
Review of Literature 3 . 1 HIV-1 discovery (2017) (0)
Biological properties of Human Immunodeficiency Virus type-1 Tat protein: angiogenic effects and adhesive interactions of extracellular Tat. (1993) (0)
Human T Cell Lymphotropic Viruses and Their Family of Diseases (1986) (0)
Human Lymphotropic Viruses (T and B Cell) and their Role in Malignancy, AIDS and Central Nervous System Disease (1987) (0)
144 Protection Against Heterologous SHIV Challenge Afforded by Immunization of Rhesus Macaques With a Subunit Immunogen that Mimics a Transition State HIV Envelope Structure (2011) (0)
Viruses and human cancer : proceedings of a UCLA Symposium on Viruses and Human Cancer, held in Park City, Utah, February 2-9, 1986 (1987) (0)
The origin and evolution of tumor viruses: implications for leukocyte differentiation and leukemia in man. (1975) (0)
Role of the Human Retroviruses HTLV-I, HTLV-II and HIV in Leukemia and AIDS (1988) (0)
Is the Birth of New "Display" Standards the Death of Fund Accounting?. (1994) (0)
Cooperation of HIV-1 Tat protein, inflammatory cytokines or bFGF in the pathogenesis of AIDS-Kaposis’s sarcoma. (1994) (0)
Correction for Zella et al., Mycoplasma promotes malignant transformation in vivo, and its DnaK, a bacterial chaperon protein, has broad oncogenic properties (2019) (0)
ISOLATION OF HUMAN HERPESVIRUS-8 (HHV-8) FROM PBMC OF AIDS-KS PATIENTS AND VIRAL TRANSMISSION TO PRIMARY CELL CULTURE: 72 (1997) (0)
Antigens of HTLV-I and/or - III and their antibodies as clinical criteria for the efficacy of lentinan administration (1985) (0)
On the historical origins of HIV-1 (MN) and (RF). (1992) (0)
[Lymphotropic retroviruses of human T lymphocytes: T lymphocyte leukemia-lymphoma of the adult and acquired immunodeficiency syndrome]. (1986) (0)
Receptor 4 in Resting CD 4 the Expression of Surface CXC-Chemokine Extracellular HIV-1 Tat Protein UpRegulates Gallo and (1999) (0)
Human T-cell growth factor ( interleukin 2 ) and y-interferon genes : Expression in human T-lymphotropic virus type III-and type I-infected cells ( mRNA abundance / gene induction / transcriptional regulation / acquired immune deficiency syndrome / leukemia ) (0)
High Level Transcription of a Human Gene in HTLV Positive T-Cells: cDNA Cloning and Characterization (1984) (0)
DNA POLYMERASES OF HUMAN NORMAL AND LEUKEMIC CELLS (1980) (0)
The human T-cell leukemia virus family, adult T cell leukemia, and AIDS. (1985) (0)
Differentiation and Function of Hematopoietic Cell Surfaces: Proceedings of the UCLA symposium held at Keystone, Colorado, February 15-20, 1981 (1982) (0)
Prospects for AIDS vaccines (2002) (0)
The origin and evolution of tumor viruses: implications for leukocyte differentiation and leukemia in man. (1975) (0)
Post-HAART therapy research. (1998) (0)
Gallo on the go. Interview by Brett Grodeck. (1995) (0)
Human leukemia viruses: the HTLV family and their role in human malignancies and immune deficiency disease (1985) (0)
Spongiform Degeneration of the Brain Associated with Uremia in an Aged Coyote (Canis Zatrans) (1994) (0)
The role of oncogenes and an understanding of the pathogenesis of cancer. (1987) (0)
Type-C viruses and leukemia. (1976) (0)
Sequential HTLV-III antibody studies in Danish homosexual men. (1987) (0)
Life cycle of RNA oncogenic viruses. (1974) (0)
The human T-cell leukemia/lymphotropic viruses: recent developments. (1986) (0)
1986 Runme Shaw memorial lecture: The role of viruses & AIDS in cancer. (1987) (0)
AIDS as a disease of body and spirit (1997) (0)
Comprehensive studies on HTLV-1/ATL in Japan. (1991) (0)
Letter from Robert C. Gallo to Marshall W. Nirenberg (1972) (0)
Mechanisms of Oncogenesis (2003) (0)
Researchers Identify New Strain of HIV Derived from Gorillas (2017) (0)
Retroviral Review@@@Retrovirus Biology and Human Disease (1990) (0)
T cell malignancies and human T cell leukemia (lymphotropic) retroviruses (HTLV). (1985) (0)
The role of oncogenes and an understanding of the pathogenesis of cancer. (1987) (0)
Retroviral Vectors and Gene Therapy (2003) (0)
Multiple sclerosis and viruses (2007) (0)
Best Practice & Research Clinical Haematology (2011) (0)
Gallo Faults ORI, Pasteur Institute (1993) (0)
Effect of type C viral expression and cellular karyotype on human B-lymphoblast tumorigenicity in nude mice. (1982) (0)
AIDS IN THE TWENTY-FIRST CENTURY : A Challenge for Biosciences (2003) (0)
Viruses, cancer and Aids: today and tomorrow (1988) (0)
Gallo on the go. Interview by Brett Grodeck. (1995) (0)
HBZ RNA may promote cell survival against clastogenic damages and thereby contributes to the development of leukemic ATL cells (2014) (0)
On the historical origins of HIV-1 (MN) and (RF). (1992) (0)
The treatment of AIDS and cancer in the third millennium. (1995) (0)
Type-C viruses and leukemia. (1976) (0)
Detection of HHV-6 antibody in Beijing. (1990) (0)
Blood Cell Biochemistry (1971) (0)
- 1799-1-9372 TITLE : Retroviral Transfer of Human Mutated Thymidylate Synthase Gene ijrito Hematopoietic Stem Cells for Protection from High-Dose Fluoropyrimidine Toxicity (0)
NOVEL BIOLOGICAL APPROACHES TO HIV AND HIV DISEASE. (1998) (0)
Letter from Robert C. Gallo to Maxine Singer (1992) (0)
Human T cell leukemia-lymphoma virus: Characterization, biology and significance (1982) (0)
Recombinant HIV-specific vaccine from poxviru (1992) (0)
AIDS Research Towards the Future (1995) (0)
I-111 Closing remarks (2017) (0)
Information , Inspiration and Advocacy for People Living with HIV / AIDS (2004) (0)
The Future of Informalism in the Economic Integration of ASEAN (2021) (0)
Post-HAART therapy research. (1998) (0)
Five cases of pnuemocystis carinii Pneumonia (PCP), a rare opportunistic infection in immunocompromised persons, were reported in previously healthy and young gay men from Los Angeles in 1981 (2012) (0)
Reverse transcriptase and neoplasia. (1973) (0)
RNA tumor viruses and human leukemia. (1978) (0)
The World ’ s Most Important AIDS Research ? (0)
The discovery of human retroviruses and how they cause disease (2007) (0)
A LAUDATIO FOR DR. YOHEI ITO (1923-1985) (1985) (0)
Comprehensive studies on HTLV-1/ATL in Japan. (1991) (0)
Kaposi's sarcoma and AIDS (1990) (0)
HTLV-III and the Etiology of AIDS (Part 1 of 2) (1986) (0)
Mark Wainberg. (2017) (0)
Personal reflections on the origin of human leukemia. (1987) (0)
H-101 Introduction to lifetime achievement awards (2017) (0)
Editorial: Terminal transferase and leukemia. (1975) (0)
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide (2022) (0)
Molecular cloning of HIV-1 and their use (1991) (0)
Human "T" leukemia virus still suspected in AIDS. Interview by John Maurice. (1983) (0)
Letter from Robert C. Gallo, National Institutes of Health to Harold Varmus (1982) (0)
1986 Runme Shaw memorial lecture: The role of viruses & AIDS in cancer. (1987) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; mechanisms of pathogenesis of human retroviruses (1989) (0)
Intracellular immunization against HIV-1 by poly-TAR RNA elements (1991) (0)
Discoveries of Novel Biological Means of Controlling HIV and HIV Disease (2000) (0)
A Tribute to Maurice Ralph Hilleman (2005) (0)
Adeno-hiv Recombinant Vaccines (1993) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; plenary session transcript; future prospects (1989) (0)
Letter: Reverse transcriptase in acute leukaemia. (1974) (0)
Notices of Books (1946) (0)
AIDS pandemic. (1986) (0)
Commentary remarks on “HIV/AIDS in China” (2005) (0)
CCR5: Window of Biocapitalism Myles W. Jackson The Genealogy of a Gene: Patents, HIV/AIDS, and Race 2015 MIT Press Cambridge 344 pp. $35.00 (2015) (0)
Robert C. Gallo, M.D. [Interview by Vicki P Glaser]. (2002) (0)
Biological treatment approaches, including Tat toxoid vaccine: interview with Robert Gallo, M.D. Interview by John S. James. (1999) (0)
Biological And Molecular Properties Of Hiv - 1 Integrase Defective Mutants (1993) (0)
[AIDS as a disease of body and spirit]. (1997) (0)
A global virus network and a perspective on viral infections in humans (2012) (0)
Science Magazine (2012) (0)
Contributors (2015) (0)
A personal perspective on HIV-AIDS research. (1999) (0)
Brief reviews (1974) (0)
Humanherpes virus-6 increases HIV-1expression in co-infected T cells vianuclear factors binding tothe HIV-1enhancer (1989) (0)
Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies (2023) (0)
Viruses and the pathogenesis of human leukemia. (1977) (0)
The Good, the Bad, and the Beautiful: Discovering Retroviruses: Beacons in the Biosphere by Anna MarieSkalkaHarvard University Press, Cambridge, MA, USA, 2018 (2019) (0)
Contents, Vol. 82, 1987 (1987) (0)
Muscular Abnormalities in the HIV-1 Transgenic Rat (2001) (0)
Cytopathic Infection Of Natural Killer (nk) Cells By Hiv-6: Induction Of Cd4 And Susceptibility To Hiv-1 Infection (1993) (0)
Inverse correlation between average monthly high temperatures and COVID-19-related death rates in different geographical areas (2020) (0)
183 Morphogenomic immune responsiveness to preventive/therapeutic vaccines (2009) (0)
Viruses and human cancer : proceedings of a UCLA Symposium held in Park City, Utah, February 2-9, 1986 (1987) (0)
G-111 DNA prime/subunit boost using SIVE660 based rhFLSC yields 75% efficacy against cross clade SIVmac251 intrarectal challenge: (2016) (0)
In Honour of Paul Kallós (1987) (0)
B-106 Development of anti-tumor cytotoxic lymphocytes using engineered human primary blood dendritic cells (2018) (0)

This paper list is powered by the following services:

Other Resources About Robert Gallo

en.wikipedia.org

What Schools Are Affiliated With Robert Gallo?

Robert Gallo is affiliated with the following schools:

Image Attributions

Image Source for Robert Gallo